CPT4
Current Procedural Terminology (CPT®)
CPT (Current Procedural Terminology) codes, often referred to as CPT-4 codes, are a set of medical codes used for reporting medical, surgical, and diagnostic procedures and services. Developed and maintained by the American Medical Association (AMA), these codes serve as a universal language among healthcare providers, payers, and facilities, ensuring a standardized system for describing healthcare procedures and services. CPT codes are integral in the billing process, as they allow healthcare providers to communicate accurately and efficiently with insurance companies about the procedures and services performed on a patient. This ensures that providers are reimbursed correctly for their services. Moreover, CPT codes are used for a variety of administrative purposes, including tracking healthcare utilization, measuring performance, and identifying treatment patterns and trends. These codes are also essential in research and policy development for the assessment of healthcare outcomes and resource allocation. Each CPT code is a unique five-digit numeric code that precisely defines the type of service or procedure performed, thereby streamlining the process of filing and processing insurance claims and enhancing the efficiency of the healthcare system.
CPT4 codes starting with 8
- 80047Basic metabolic panel (Calcium, ionized) This panel must include the following: Calcium, ionized (82330) Carbon dioxide (bicarbonate) (82374) Chloride (82435) Creatinine (82565) Glucose (82947) Potassium (84132) Sodium (84295) Urea Nitrogen (BUN) (84520)CPT4
- 80048Basic metabolic panel (Calcium, total) This panel must include the following: Calcium, total (82310) Carbon dioxide (bicarbonate) (82374) Chloride (82435) Creatinine (82565) Glucose (82947) Potassium (84132) Sodium (84295) Urea nitrogen (BUN) (84520)CPT4
- 80050General health panel This panel must include the following: Comprehensive metabolic panel (80053) Blood count, complete (CBC), automated and automated differential WBC count (85025 or 85027 and 85004) OR Blood count, complete (CBC), automated (85027) and CPT4
- 80051Electrolyte panel This panel must include the following: Carbon dioxide (bicarbonate) (82374) Chloride (82435) Potassium (84132) Sodium (84295)CPT4
- 80053Comprehensive metabolic panel This panel must include the following: Albumin (82040) Bilirubin, total (82247) Calcium, total (82310) Carbon dioxide (bicarbonate) (82374) Chloride (82435) Creatinine (82565) Glucose (82947) Phosphatase, alkaline (84075) PotCPT4
- 80055Obstetric panel This panel must include the following: Blood count, complete (CBC), automated and automated differential WBC count (85025 or 85027 and 85004) OR Blood count, complete (CBC), automated (85027) and appropriate manual differential WBC count (CPT4
- 80061Lipid panel This panel must include the following: Cholesterol, serum, total (82465) Lipoprotein, direct measurement, high density cholesterol (HDL cholesterol) (83718) Triglycerides (84478)CPT4
- 80069Renal function panel This panel must include the following: Albumin (82040) Calcium, total (82310) Carbon dioxide (bicarbonate) (82374) Chloride (82435) Creatinine (82565) Glucose (82947) Phosphorus inorganic (phosphate) (84100) Potassium (84132) Sodium (CPT4
- 80074Acute hepatitis panel This panel must include the following: Hepatitis A antibody (HAAb), IgM antibody (86709) Hepatitis B core antibody (HBcAb), IgM antibody (86705) Hepatitis B surface antigen (HBsAg) (87340) Hepatitis C antibody (86803)CPT4
- 80076Hepatic function panel This panel must include the following: Albumin (82040) Bilirubin, total (82247) Bilirubin, direct (82248) Phosphatase, alkaline (84075) Protein, total (84155) Transferase, alanine amino (ALT) (SGPT) (84460) Transferase, aspartate amCPT4
- 80081Obstetric panel (includes HIV testing) This panel must include the following: Blood count, complete (CBC), and automated differential WBC count (85025 or 85027 and 85004) OR Blood count, complete (CBC), automated (85027) and appropriate manual differentiaCPT4
- 80100Drug screen, qualitative; multiple drug classes chromatographic method, each procedureCPT4
- 80101Drug screen, qualitative; single drug class method (eg, immunoassay, enzyme assay), each drug classCPT4
- 80104Drug screen, qualitative; multiple drug classes other than chromatographic method, each procedureCPT4
- 80143AcetaminophenCPT4
- 80145AdalimumabCPT4
- 80150AmikacinCPT4
- 80151AmiodaroneCPT4
- 80154BenzodiazepinesCPT4
- 80155CaffeineCPT4
- 80156Carbamazepine; totalCPT4
- 80157Carbamazepine; freeCPT4
- 80158CyclosporineCPT4
- 80159ClozapineCPT4
- 80160DesipramineCPT4
- 80161Carbamazepine; -10,11-epoxideCPT4
- 80162Digoxin; totalCPT4
- 80164Valproic acid (dipropylacetic acid); totalCPT4
- 80165Valproic acid (dipropylacetic acid); freeCPT4
- 80168EthosuximideCPT4
- 80169EverolimusCPT4
- 80170GentamicinCPT4
- 80171Gabapentin, whole blood, serum, or plasmaCPT4
- 80173HaloperidolCPT4
- 80175LamotrigineCPT4
- 80176LidocaineCPT4
- 80177LevetiracetamCPT4
- 80178LithiumCPT4
- 80179SalicylateCPT4
- 80180Mycophenolate (mycophenolic acid)CPT4
- 80181FlecainideCPT4
- 80183OxcarbazepineCPT4
- 80184PhenobarbitalCPT4
- 80185Phenytoin; totalCPT4
- 80186Phenytoin; freeCPT4
- 80187PosaconazoleCPT4
- 80188PrimidoneCPT4
- 80193LeflunomideCPT4
- 80194QuinidineCPT4
- 80195SirolimusCPT4
- 80197TacrolimusCPT4
- 80198TheophyllineCPT4
- 80199TiagabineCPT4
- 80200TobramycinCPT4
- 80201TopiramateCPT4
- 80202VancomycinCPT4
- 80203ZonisamideCPT4
- 80210RufinamideCPT4
- 80230InfliximabCPT4
- 80235LacosamideCPT4
- 80280VedolizumabCPT4
- 80285VoriconazoleCPT4
- 80299Quantitation of therapeutic drug, not elsewhere specifiedCPT4
- 80300Drug screen, any number of drug classes from Drug Class List A; any number of non-TLC devices or procedures, (eg, immunoassay) capable of being read by direct optical observation, including instrumented-assisted when performed (eg, dipsticks, cups, cards,CPT4
- 80301Drug screen, any number of drug classes from Drug Class List A; single drug class method, by instrumented test systems (eg, discrete multichannel chemistry analyzers utilizing immunoassay or enzyme assay), per date of serviceCPT4
- 80302Drug screen, presumptive, single drug class from Drug Class List B, by immunoassay (eg, ELISA) or non-TLC chromatography without mass spectrometry (eg, GC, HPLC), each procedureCPT4
- 80303Drug screen, any number of drug classes, presumptive, single or multiple drug class method; thin layer chromatography procedure(s) (TLC) (eg, acid, neutral, alkaloid plate), per date of serviceCPT4
- 80304Drug screen, any number of drug classes, presumptive, single or multiple drug class method; not otherwise specified presumptive procedure (eg, TOF, MALDI, LDTD, DESI, DART), each procedureCPT4
- 80305Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; capable of being read by direct optical observation only (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when pCPT4
- 80306Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; read by instrument assisted direct optical observation (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when perCPT4
- 80307Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry eitCPT4
- 80320AlcoholsCPT4
- 80321Alcohol biomarkers; 1 or 2CPT4
- 80323Alkaloids, not otherwise specifiedCPT4
- 80324Amphetamines; 1 or 2CPT4
- 80325Amphetamines; 3 or 4CPT4
- 80326Amphetamines; 5 or moreCPT4
- 80327Anabolic steroids; 1 or 2CPT4
- 80329Analgesics, non-opioid; 1 or 2CPT4
- 80330Analgesics, non-opioid; 3-5CPT4
- 80331Analgesics, non-opioid; 6 or moreCPT4
- 80332Antidepressants, serotonergic class; 1 or 2CPT4
- 80333Antidepressants, serotonergic class; 3-5CPT4
- 80334Antidepressants, serotonergic class; 6 or moreCPT4
- 80335Antidepressants, tricyclic and other cyclicals; 1 or 2CPT4
- 80336Antidepressants, tricyclic and other cyclicals; 3-5CPT4
- 80337Antidepressants, tricyclic and other cyclicals; 6 or moreCPT4
- 80338Antidepressants, not otherwise specifiedCPT4
- 80339Antiepileptics, not otherwise specified; 1-3CPT4
- 80340Antiepileptics, not otherwise specified; 4-6CPT4
- 80341Antiepileptics, not otherwise specified; 7 or moreCPT4
- 80342Antipsychotics, not otherwise specified; 1-3CPT4
- 80343Antipsychotics, not otherwise specified; 4-6CPT4
- 80344Antipsychotics, not otherwise specified; 7 or moreCPT4
- 80345BarbituratesCPT4
- 80346Benzodiazepines; 1-12CPT4
- 80347Benzodiazepines; 13 or moreCPT4
- 80348BuprenorphineCPT4
- 80349Cannabinoids, naturalCPT4
- 80350Cannabinoids, synthetic; 1-3CPT4
- 80352Cannabinoids, synthetic; 7 or moreCPT4
- 80353CocaineCPT4
- 80354FentanylCPT4
- 80355Gabapentin, non-bloodCPT4
- 80356Heroin metaboliteCPT4
- 80357Ketamine and norketamineCPT4
- 80358MethadoneCPT4
- 80359Methylenedioxyamphetamines (MDA, MDEA, MDMA)CPT4
- 80360MethylphenidateCPT4
- 80361Opiates, 1 or moreCPT4
- 80362Opioids and opiate analogs; 1 or 2CPT4
- 80363Opioids and Opiate analogs; 3 or 4CPT4
- 80364Opioids and Opiate analogs; 5 or moreCPT4
- 80365OxycodoneCPT4
- 80366PregabalinCPT4
- 80367PropoxypheneCPT4
- 80368Sedative hypnotics (non-benzodiazepines)CPT4
- 80369Skeletal muscle relaxants; 1 or 2CPT4
- 80370Skeletal muscle relaxants; 3 or moreCPT4
- 80371Stimulants, syntheticCPT4
- 80372TapentadolCPT4
- 80373TramadolCPT4
- 80374Stereoisomer (enantiomer) analysis, single drug classCPT4
- 80375Drug(s) or substance(s), definitive, qualitative or quantitative, not otherwise specified; 1-3CPT4
- 80377Drug(s) or substance(s), definitive, qualitative or quantitative, not otherwise specified; 7 or moreCPT4
- 80400ACTH stimulation panel; for adrenal insufficiency This panel must include the following: Cortisol (82533 x 2)CPT4
- 80402ACTH stimulation panel; for 21 hydroxylase deficiency This panel must include the following: Cortisol (82533 x 2) 17 hydroxyprogesterone (83498 x 2)CPT4
- 80406ACTH stimulation panel; for 3 beta-hydroxydehydrogenase deficiency This panel must include the following: Cortisol (82533 x 2) 17 hydroxypregnenolone (84143 x 2)CPT4
- 80408Aldosterone suppression evaluation panel (eg, saline infusion) This panel must include the following: Aldosterone (82088 x 2) Renin (84244 x 2)CPT4
- 80410Calcitonin stimulation panel (eg, calcium, pentagastrin) This panel must include the following: Calcitonin (82308 x 3)CPT4
- 80414Chorionic gonadotropin stimulation panel; testosterone response This panel must include the following: Testosterone (84403 x 2 on 3 pooled blood samples)CPT4
- 80415Chorionic gonadotropin stimulation panel; estradiol response This panel must include the following: Estradiol, total (82670 x 2 on 3 pooled blood samples)CPT4
- 80422Glucagon tolerance panel; for insulinoma This panel must include the following: Glucose (82947 x 3) Insulin (83525 x 3)CPT4
- 80424Glucagon tolerance panel; for pheochromocytoma This panel must include the following: Catecholamines, fractionated (82384 x 2)CPT4
- 80428Growth hormone stimulation panel (eg, arginine infusion, l-dopa administration) This panel must include the following: Human growth hormone (HGH) (83003 x 4)CPT4
- 80430Growth hormone suppression panel (glucose administration) This panel must include the following: Glucose (82947 x 3) Human growth hormone (HGH) (83003 x 4)CPT4
- 80436Metyrapone panel This panel must include the following: Cortisol (82533 x 2) 11 deoxycortisol (82634 x 2)CPT4
- 80438Thyrotropin releasing hormone (TRH) stimulation panel; 1 hour This panel must include the following: Thyroid stimulating hormone (TSH) (84443 x 3)CPT4
- 80500Clinical pathology consultation; limited, without review of patient's history and medical recordsCPT4
- 80502Clinical pathology consultation; comprehensive, for a complex diagnostic problem, with review of patient's history and medical recordsCPT4
- 81000Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, with microscopyCPT4
- 81001Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopyCPT4
- 81002Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopyCPT4
- 81003Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopyCPT4
- 81005Urinalysis; qualitative or semiquantitative, except immunoassaysCPT4
- 81007Urinalysis; bacteriuria screen, except by culture or dipstickCPT4
- 81015Urinalysis; microscopic onlyCPT4
- 81020Urinalysis; 2 or 3 glass testCPT4
- 81025Urine pregnancy test, by visual color comparison methodsCPT4
- 81050Volume measurement for timed collection, eachCPT4
- 81099Unlisted urinalysis procedureCPT4
- 81105Human Platelet Antigen 1 genotyping (HPA-1), ITGB3 (integrin, beta 3 [platelet glycoprotein IIIa], antigen CD61 [GPIIIa]) (eg, neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura), gene analysis, common variant, HPA-1a/b (L33P)CPT4
- 81120IDH1 (isocitrate dehydrogenase 1 [NADP+], soluble) (eg, glioma), common variants (eg, R132H, R132C)CPT4
- 81121IDH2 (isocitrate dehydrogenase 2 [NADP+], mitochondrial) (eg, glioma), common variants (eg, R140W, R172M)CPT4
- 81161DMD (dystrophin) (eg, Duchenne/Becker muscular dystrophy) deletion analysis, and duplication analysis, if performedCPT4
- 81162BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysis and full duplication/deletion analysis (ie, detection of large gene rearrangements)CPT4
- 81163BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysisCPT4
- 81164BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full duplication/deletion analysis (ie, detection of large gene rearrangements)CPT4
- 81165BRCA1 (BRCA1, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysisCPT4
- 81170ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase) (eg, acquired imatinib tyrosine kinase inhibitor resistance), gene analysis, variants in the kinase domainCPT4
- 81173AR (androgen receptor) (eg, spinal and bulbar muscular atrophy, Kennedy disease, X chromosome inactivation) gene analysis; full gene sequenceCPT4
- 81175ASXL1 (additional sex combs like 1, transcriptional regulator) (eg, myelodysplastic syndrome, myeloproliferative neoplasms, chronic myelomonocytic leukemia), gene analysis; full gene sequenceCPT4
- 81176ASXL1 (additional sex combs like 1, transcriptional regulator) (eg, myelodysplastic syndrome, myeloproliferative neoplasms, chronic myelomonocytic leukemia), gene analysis; targeted sequence analysis (eg, exon 12)CPT4
- 81177ATN1 (atrophin 1) (eg, dentatorubral-pallidoluysian atrophy) gene analysis, evaluation to detect abnormal (eg, expanded) allelesCPT4
- 81179ATXN2 (ataxin 2) (eg, spinocerebellar ataxia) gene analysis, evaluation to detect abnormal (eg, expanded) allelesCPT4
- 81180ATXN3 (ataxin 3) (eg, spinocerebellar ataxia, Machado-Joseph disease) gene analysis, evaluation to detect abnormal (eg, expanded) allelesCPT4
- 81181ATXN7 (ataxin 7) (eg, spinocerebellar ataxia) gene analysis, evaluation to detect abnormal (eg, expanded) allelesCPT4
- 81182ATXN8OS (ATXN8 opposite strand [non-protein coding]) (eg, spinocerebellar ataxia) gene analysis, evaluation to detect abnormal (eg, expanded) allelesCPT4
- 81183ATXN10 (ataxin 10) (eg, spinocerebellar ataxia) gene analysis, evaluation to detect abnormal (eg, expanded) allelesCPT4
- 81184CACNA1A (calcium voltage-gated channel subunit alpha1 A) (eg, spinocerebellar ataxia) gene analysis; evaluation to detect abnormal (eg, expanded) allelesCPT4
- 81185CACNA1A (calcium voltage-gated channel subunit alpha1 A) (eg, spinocerebellar ataxia) gene analysis; full gene sequenceCPT4
- 81187CNBP (CCHC-type zinc finger nucleic acid binding protein) (eg, myotonic dystrophy type 2) gene analysis, evaluation to detect abnormal (eg, expanded) allelesCPT4
- 81189CSTB (cystatin B) (eg, Unverricht-Lundborg disease) gene analysis; full gene sequenceCPT4
- 81191NTRK1 (neurotrophic receptor tyrosine kinase 1) (eg, solid tumors) translocation analysisCPT4
- 81194NTRK (neurotrophic-tropomyosin receptor tyrosine kinase 1, 2, and 3) (eg, solid tumors) translocation analysisCPT4
- 81200ASPA (aspartoacylase) (eg, Canavan disease) gene analysis, common variants (eg, E285A, Y231X)CPT4
- 81201APC (adenomatous polyposis coli) (eg, familial adenomatosis polyposis [FAP], attenuated FAP) gene analysis; full gene sequenceCPT4
- 81202APC (adenomatous polyposis coli) (eg, familial adenomatosis polyposis [FAP], attenuated FAP) gene analysis; known familial variantsCPT4
- 81203APC (adenomatous polyposis coli) (eg, familial adenomatosis polyposis [FAP], attenuated FAP) gene analysis; duplication/deletion variantsCPT4
- 81204AR (androgen receptor) (eg, spinal and bulbar muscular atrophy, Kennedy disease, X chromosome inactivation) gene analysis; characterization of alleles (eg, expanded size or methylation status)CPT4
- 81205BCKDHB (branched-chain keto acid dehydrogenase E1, beta polypeptide) (eg, maple syrup urine disease) gene analysis, common variants (eg, R183P, G278S, E422X)CPT4
- 81206BCR/ABL1 (t(9;22)) (eg, chronic myelogenous leukemia) translocation analysis; major breakpoint, qualitative or quantitativeCPT4
- 81207BCR/ABL1 (t(9;22)) (eg, chronic myelogenous leukemia) translocation analysis; minor breakpoint, qualitative or quantitativeCPT4
- 81208BCR/ABL1 (t(9;22)) (eg, chronic myelogenous leukemia) translocation analysis; other breakpoint, qualitative or quantitativeCPT4
- 81209BLM (Bloom syndrome, RecQ helicase-like) (eg, Bloom syndrome) gene analysis, 2281del6ins7 variantCPT4
- 81210BRAF (B-Raf proto-oncogene, serine/threonine kinase) (eg, colon cancer, melanoma), gene analysis, V600 variant(s)CPT4
- 81211BRCA1, BRCA2 (breast cancer 1 and 2) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysis and common duplication/deletion variants in BRCA1 (ie, exon 13 del 3.835kb, exon 13 dup 6kb, exon 14-20 del 26kb, exon 22 del 510bp, exonCPT4
- 81212BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; 185delAG, 5385insC, 6174delT variantsCPT4
- 81213BRCA1, BRCA2 (breast cancer 1 and 2) (eg, hereditary breast and ovarian cancer) gene analysis; uncommon duplication/deletion variantsCPT4
- 81214BRCA1 (breast cancer 1) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysis and common duplication/deletion variants (ie, exon 13 del 3.835kb, exon 13 dup 6kb, exon 14-20 del 26kb, exon 22 del 510bp, exon 8-9 del 7.1kb)CPT4
- 81215BRCA1 (BRCA1, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; known familial variantCPT4
- 81216BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysisCPT4
- 81217BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; known familial variantCPT4
- 81218CEBPA (CCAAT/enhancer binding protein [C/EBP], alpha) (eg, acute myeloid leukemia), gene analysis, full gene sequenceCPT4
- 81219CALR (calreticulin) (eg, myeloproliferative disorders), gene analysis, common variants in exon 9CPT4
- 81220CFTR (cystic fibrosis transmembrane conductance regulator) (eg, cystic fibrosis) gene analysis; common variants (eg, ACMG/ACOG guidelines)CPT4
- 81221CFTR (cystic fibrosis transmembrane conductance regulator) (eg, cystic fibrosis) gene analysis; known familial variantsCPT4
- 81222CFTR (cystic fibrosis transmembrane conductance regulator) (eg, cystic fibrosis) gene analysis; duplication/deletion variantsCPT4
- 81223CFTR (cystic fibrosis transmembrane conductance regulator) (eg, cystic fibrosis) gene analysis; full gene sequenceCPT4
- 81224CFTR (cystic fibrosis transmembrane conductance regulator) (eg, cystic fibrosis) gene analysis; intron 8 poly-T analysis (eg, male infertility)CPT4
- 81225CYP2C19 (cytochrome P450, family 2, subfamily C, polypeptide 19) (eg, drug metabolism), gene analysis, common variants (eg, *2, *3, *4, *8, *17)CPT4
- 81226CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism), gene analysis, common variants (eg, *2, *3, *4, *5, *6, *9, *10, *17, *19, *29, *35, *41, *1XN, *2XN, *4XN)CPT4
- 81227CYP2C9 (cytochrome P450, family 2, subfamily C, polypeptide 9) (eg, drug metabolism), gene analysis, common variants (eg, *2, *3, *5, *6)CPT4
- 81228Cytogenomic constitutional (genome-wide) microarray analysis; interrogation of genomic regions for copy number variants (eg, bacterial artificial chromosome [BAC] or oligo-based comparative genomic hybridization [CGH] microarray analysis)CPT4
- 81229Cytogenomic constitutional (genome-wide) microarray analysis; interrogation of genomic regions for copy number and single nucleotide polymorphism (SNP) variants for chromosomal abnormalitiesCPT4
- 81230CYP3A4 (cytochrome P450 family 3 subfamily A member 4) (eg, drug metabolism), gene analysis, common variant(s) (eg, *2, *22)CPT4
- 81231CYP3A5 (cytochrome P450 family 3 subfamily A member 5) (eg, drug metabolism), gene analysis, common variants (eg, *2, *3, *4, *5, *6, *7)CPT4
- 81232DPYD (dihydropyrimidine dehydrogenase) (eg, 5-fluorouracil/5-FU and capecitabine drug metabolism), gene analysis, common variant(s) (eg, *2A, *4, *5, *6)CPT4
- 81234DMPK (DM1 protein kinase) (eg, myotonic dystrophy type 1) gene analysis; evaluation to detect abnormal (expanded) allelesCPT4
- 81235EGFR (epidermal growth factor receptor) (eg, non-small cell lung cancer) gene analysis, common variants (eg, exon 19 LREA deletion, L858R, T790M, G719A, G719S, L861Q)CPT4
- 81236EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit) (eg, myelodysplastic syndrome, myeloproliferative neoplasms) gene analysis, full gene sequenceCPT4
- 81237EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit) (eg, diffuse large B-cell lymphoma) gene analysis, common variant(s) (eg, codon 646)CPT4
- 81238F9 (coagulation factor IX) (eg, hemophilia B), full gene sequenceCPT4
- 81240F2 (prothrombin, coagulation factor II) (eg, hereditary hypercoagulability) gene analysis, 20210G>A variantCPT4
- 81241F5 (coagulation factor V) (eg, hereditary hypercoagulability) gene analysis, Leiden variantCPT4
- 81242FANCC (Fanconi anemia, complementation group C) (eg, Fanconi anemia, type C) gene analysis, common variant (eg, IVS4+4A>T)CPT4
- 81243FMR1 (fragile X mental retardation 1) (eg, fragile X mental retardation) gene analysis; evaluation to detect abnormal (eg, expanded) allelesCPT4
- 81244FMR1 (fragile X mental retardation 1) (eg, fragile X mental retardation) gene analysis; characterization of alleles (eg, expanded size and promoter methylation status)CPT4
- 81245FLT3 (fms-related tyrosine kinase 3) (eg, acute myeloid leukemia), gene analysis; internal tandem duplication (ITD) variants (ie, exons 14, 15)CPT4
- 81246FLT3 (fms-related tyrosine kinase 3) (eg, acute myeloid leukemia), gene analysis; tyrosine kinase domain (TKD) variants (eg, D835, I836)CPT4
- 81247G6PD (glucose-6-phosphate dehydrogenase) (eg, hemolytic anemia, jaundice), gene analysis; common variant(s) (eg, A, A-)CPT4
- 81249G6PD (glucose-6-phosphate dehydrogenase) (eg, hemolytic anemia, jaundice), gene analysis; full gene sequenceCPT4
- 81250G6PC (glucose-6-phosphatase, catalytic subunit) (eg, Glycogen storage disease, type 1a, von Gierke disease) gene analysis, common variants (eg, R83C, Q347X)CPT4
- 81251GBA (glucosidase, beta, acid) (eg, Gaucher disease) gene analysis, common variants (eg, N370S, 84GG, L444P, IVS2+1G>A)CPT4
- 81252GJB2 (gap junction protein, beta 2, 26kDa, connexin 26) (eg, nonsyndromic hearing loss) gene analysis; full gene sequenceCPT4
- 81253GJB2 (gap junction protein, beta 2, 26kDa, connexin 26) (eg, nonsyndromic hearing loss) gene analysis; known familial variantsCPT4
- 81254GJB6 (gap junction protein, beta 6, 30kDa, connexin 30) (eg, nonsyndromic hearing loss) gene analysis, common variants (eg, 309kb [del(GJB6-D13S1830)] and 232kb [del(GJB6-D13S1854)])CPT4
- 81255HEXA (hexosaminidase A [alpha polypeptide]) (eg, Tay-Sachs disease) gene analysis, common variants (eg, 1278insTATC, 1421+1G>C, G269S)CPT4
- 81256HFE (hemochromatosis) (eg, hereditary hemochromatosis) gene analysis, common variants (eg, C282Y, H63D)CPT4
- 81257HBA1/HBA2 (alpha globin 1 and alpha globin 2) (eg, alpha thalassemia, Hb Bart hydrops fetalis syndrome, HbH disease), gene analysis; common deletions or variant (eg, Southeast Asian, Thai, Filipino, Mediterranean, alpha3.7, alpha4.2, alpha20.5, Constant SCPT4
- 81259HBA1/HBA2 (alpha globin 1 and alpha globin 2) (eg, alpha thalassemia, Hb Bart hydrops fetalis syndrome, HbH disease), gene analysis; full gene sequenceCPT4
- 81260IKBKAP (inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein) (eg, familial dysautonomia) gene analysis, common variants (eg, 2507+6T>C, R696P)CPT4
- 81261IGH@ (Immunoglobulin heavy chain locus) (eg, leukemias and lymphomas, B-cell), gene rearrangement analysis to detect abnormal clonal population(s); amplified methodology (eg, polymerase chain reaction)CPT4
- 81263IGH@ (Immunoglobulin heavy chain locus) (eg, leukemia and lymphoma, B-cell), variable region somatic mutation analysisCPT4
- 81264IGK@ (Immunoglobulin kappa light chain locus) (eg, leukemia and lymphoma, B-cell), gene rearrangement analysis, evaluation to detect abnormal clonal population(s)CPT4
- 81265Comparative analysis using Short Tandem Repeat (STR) markers; patient and comparative specimen (eg, pre-transplant recipient and donor germline testing, post-transplant non-hematopoietic recipient germline [eg, buccal swab or other germline tissue sample]CPT4
- 81266Comparative analysis using Short Tandem Repeat (STR) markers; each additional specimen (eg, additional cord blood donor, additional fetal samples from different cultures, or additional zygosity in multiple birth pregnancies) (List separately in addition tCPT4
- 81267Chimerism (engraftment) analysis, post transplantation specimen (eg, hematopoietic stem cell), includes comparison to previously performed baseline analyses; without cell selectionCPT4
- 81268Chimerism (engraftment) analysis, post transplantation specimen (eg, hematopoietic stem cell), includes comparison to previously performed baseline analyses; with cell selection (eg, CD3, CD33), each cell typeCPT4
- 81269HBA1/HBA2 (alpha globin 1 and alpha globin 2) (eg, alpha thalassemia, Hb Bart hydrops fetalis syndrome, HbH disease), gene analysis; duplication/deletion variantsCPT4
- 81270JAK2 (Janus kinase 2) (eg, myeloproliferative disorder) gene analysis, p.Val617Phe (V617F) variantCPT4
- 81271HTT (huntingtin) (eg, Huntington disease) gene analysis; evaluation to detect abnormal (eg, expanded) allelesCPT4
- 81272KIT (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (eg, gastrointestinal stromal tumor [GIST], acute myeloid leukemia, melanoma), gene analysis, targeted sequence analysis (eg, exons 8, 11, 13, 17, 18)CPT4
- 81273KIT (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (eg, mastocytosis), gene analysis, D816 variant(s)CPT4
- 81275KRAS (Kirsten rat sarcoma viral oncogene homolog) (eg, carcinoma) gene analysis; variants in exon 2 (eg, codons 12 and 13)CPT4
- 81276KRAS (Kirsten rat sarcoma viral oncogene homolog) (eg, carcinoma) gene analysis; additional variant(s) (eg, codon 61, codon 146)CPT4
- 81277Cytogenomic neoplasia (genome-wide) microarray analysis, interrogation of genomic regions for copy number and loss-of-heterozygosity variants for chromosomal abnormalitiesCPT4
- 81279JAK2 (Janus kinase 2) (eg, myeloproliferative disorder) targeted sequence analysis (eg, exons 12 and 13)CPT4
- 81280Long QT syndrome gene analyses (eg, KCNQ1, KCNH2, SCN5A, KCNE1, KCNE2, KCNJ2, CACNA1C, CAV3, SCN4B, AKAP, SNTA1, and ANK2); full sequence analysisCPT4
- 81281Long QT syndrome gene analyses (eg, KCNQ1, KCNH2, SCN5A, KCNE1, KCNE2, KCNJ2, CACNA1C, CAV3, SCN4B, AKAP, SNTA1, and ANK2); known familial sequence variantCPT4
- 81282Long QT syndrome gene analyses (eg, KCNQ1, KCNH2, SCN5A, KCNE1, KCNE2, KCNJ2, CACNA1C, CAV3, SCN4B, AKAP, SNTA1, and ANK2); duplication/deletion variantsCPT4
- 81283IFNL3 (interferon, lambda 3) (eg, drug response), gene analysis, rs12979860 variantCPT4
- 81284FXN (frataxin) (eg, Friedreich ataxia) gene analysis; evaluation to detect abnormal (expanded) allelesCPT4
- 81286FXN (frataxin) (eg, Friedreich ataxia) gene analysis; full gene sequenceCPT4
- 81287MGMT (O-6-methylguanine-DNA methyltransferase) (eg, glioblastoma multiforme) promoter methylation analysisCPT4
- 81288MLH1 (mutL homolog 1, colon cancer, nonpolyposis type 2) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; promoter methylation analysisCPT4
- 81290MCOLN1 (mucolipin 1) (eg, Mucolipidosis, type IV) gene analysis, common variants (eg, IVS3-2A>G, del6.4kb)CPT4
- 81291MTHFR (5,10-methylenetetrahydrofolate reductase) (eg, hereditary hypercoagulability) gene analysis, common variants (eg, 677T, 1298C)CPT4
- 81292MLH1 (mutL homolog 1, colon cancer, nonpolyposis type 2) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; full sequence analysisCPT4
- 81293MLH1 (mutL homolog 1, colon cancer, nonpolyposis type 2) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; known familial variantsCPT4
- 81294MLH1 (mutL homolog 1, colon cancer, nonpolyposis type 2) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; duplication/deletion variantsCPT4
- 81295MSH2 (mutS homolog 2, colon cancer, nonpolyposis type 1) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; full sequence analysisCPT4
- 81297MSH2 (mutS homolog 2, colon cancer, nonpolyposis type 1) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; duplication/deletion variantsCPT4
- 81298MSH6 (mutS homolog 6 [E. coli]) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; full sequence analysisCPT4
- 81299MSH6 (mutS homolog 6 [E. coli]) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; known familial variantsCPT4
- 81300MSH6 (mutS homolog 6 [E. coli]) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; duplication/deletion variantsCPT4
- 81301Microsatellite instability analysis (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) of markers for mismatch repair deficiency (eg, BAT25, BAT26), includes comparison of neoplastic and normal tissue, if performedCPT4
- 81302MECP2 (methyl CpG binding protein 2) (eg, Rett syndrome) gene analysis; full sequence analysisCPT4
- 81304MECP2 (methyl CpG binding protein 2) (eg, Rett syndrome) gene analysis; duplication/deletion variantsCPT4
- 81305MYD88 (myeloid differentiation primary response 88) (eg, Waldenstrom's macroglobulinemia, lymphoplasmacytic leukemia) gene analysis, p.Leu265Pro (L265P) variantCPT4
- 81306NUDT15 (nudix hydrolase 15) (eg, drug metabolism) gene analysis, common variant(s) (eg, *2, *3, *4, *5, *6)CPT4
- 81307PALB2 (partner and localizer of BRCA2) (eg, breast and pancreatic cancer) gene analysis; full gene sequenceCPT4
- 81308PALB2 (partner and localizer of BRCA2) (eg, breast and pancreatic cancer) gene analysis; known familial variantCPT4
- 81309PIK3CA (phosphatidylinositol-4, 5-biphosphate 3-kinase, catalytic subunit alpha) (eg, colorectal and breast cancer) gene analysis, targeted sequence analysis (eg, exons 7, 9, 20)CPT4
- 81310NPM1 (nucleophosmin) (eg, acute myeloid leukemia) gene analysis, exon 12 variantsCPT4
- 81311NRAS (neuroblastoma RAS viral [v-ras] oncogene homolog) (eg, colorectal carcinoma), gene analysis, variants in exon 2 (eg, codons 12 and 13) and exon 3 (eg, codon 61)CPT4
- 81312PABPN1 (poly[A] binding protein nuclear 1) (eg, oculopharyngeal muscular dystrophy) gene analysis, evaluation to detect abnormal (eg, expanded) allelesCPT4
- 81313PCA3/KLK3 (prostate cancer antigen 3 [non-protein coding]/kallikrein-related peptidase 3 [prostate specific antigen]) ratio (eg, prostate cancer)CPT4
- 81314PDGFRA (platelet-derived growth factor receptor, alpha polypeptide) (eg, gastrointestinal stromal tumor [GIST]), gene analysis, targeted sequence analysis (eg, exons 12, 18)CPT4
- 81315PML/RARalpha, (t(15;17)), (promyelocytic leukemia/retinoic acid receptor alpha) (eg, promyelocytic leukemia) translocation analysis; common breakpoints (eg, intron 3 and intron 6), qualitative or quantitativeCPT4
- 81316PML/RARalpha, (t(15;17)), (promyelocytic leukemia/retinoic acid receptor alpha) (eg, promyelocytic leukemia) translocation analysis; single breakpoint (eg, intron 3, intron 6 or exon 6), qualitative or quantitativeCPT4
- 81317PMS2 (postmeiotic segregation increased 2 [S. cerevisiae]) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; full sequence analysisCPT4
- 81318PMS2 (postmeiotic segregation increased 2 [S. cerevisiae]) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; known familial variantsCPT4
- 81319PMS2 (postmeiotic segregation increased 2 [S. cerevisiae]) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; duplication/deletion variantsCPT4
- 81321PTEN (phosphatase and tensin homolog) (eg, Cowden syndrome, PTEN hamartoma tumor syndrome) gene analysis; full sequence analysisCPT4
- 81322PTEN (phosphatase and tensin homolog) (eg, Cowden syndrome, PTEN hamartoma tumor syndrome) gene analysis; known familial variantCPT4
- 81323PTEN (phosphatase and tensin homolog) (eg, Cowden syndrome, PTEN hamartoma tumor syndrome) gene analysis; duplication/deletion variantCPT4
- 81324PMP22 (peripheral myelin protein 22) (eg, Charcot-Marie-Tooth, hereditary neuropathy with liability to pressure palsies) gene analysis; duplication/deletion analysisCPT4
- 81325PMP22 (peripheral myelin protein 22) (eg, Charcot-Marie-Tooth, hereditary neuropathy with liability to pressure palsies) gene analysis; full sequence analysisCPT4
- 81327SEPT9 (Septin9) (eg, colorectal cancer) promoter methylation analysisCPT4
- 81328SLCO1B1 (solute carrier organic anion transporter family, member 1B1) (eg, adverse drug reaction), gene analysis, common variant(s) (eg, *5)CPT4
- 81329SMN1 (survival of motor neuron 1, telomeric) (eg, spinal muscular atrophy) gene analysis; dosage/deletion analysis (eg, carrier testing), includes SMN2 (survival of motor neuron 2, centromeric) analysis, if performedCPT4
- 81330SMPD1(sphingomyelin phosphodiesterase 1, acid lysosomal) (eg, Niemann-Pick disease, Type A) gene analysis, common variants (eg, R496L, L302P, fsP330)CPT4
- 81331SNRPN/UBE3A (small nuclear ribonucleoprotein polypeptide N and ubiquitin protein ligase E3A) (eg, Prader-Willi syndrome and/or Angelman syndrome), methylation analysisCPT4
- 81332SERPINA1 (serpin peptidase inhibitor, clade A, alpha-1 antiproteinase, antitrypsin, member 1) (eg, alpha-1-antitrypsin deficiency), gene analysis, common variants (eg, *S and *Z)CPT4
- 81334RUNX1 (runt related transcription factor 1) (eg, acute myeloid leukemia, familial platelet disorder with associated myeloid malignancy) gene analysis, targeted sequence analysis (eg, exons 3-8)CPT4
- 81335TPMT (thiopurine S-methyltransferase) (eg, drug metabolism), gene analysis, common variants (eg, *2, *3)CPT4
- 81336SMN1 (survival of motor neuron 1, telomeric) (eg, spinal muscular atrophy) gene analysis; full gene sequenceCPT4
- 81337SMN1 (survival of motor neuron 1, telomeric) (eg, spinal muscular atrophy) gene analysis; known familial sequence variant(s)CPT4
- 81338MPL (MPL proto-oncogene, thrombopoietin receptor) (eg, myeloproliferative disorder) gene analysis; common variants (eg, W515A, W515K, W515L, W515R)CPT4
- 81339MPL (MPL proto-oncogene, thrombopoietin receptor) (eg, myeloproliferative disorder) gene analysis; sequence analysis, exon 10CPT4
- 81340TRB@ (T cell antigen receptor, beta) (eg, leukemia and lymphoma), gene rearrangement analysis to detect abnormal clonal population(s); using amplification methodology (eg, polymerase chain reaction)CPT4
- 81342TRG@ (T cell antigen receptor, gamma) (eg, leukemia and lymphoma), gene rearrangement analysis, evaluation to detect abnormal clonal population(s)CPT4
- 81343PPP2R2B (protein phosphatase 2 regulatory subunit Bbeta) (eg, spinocerebellar ataxia) gene analysis, evaluation to detect abnormal (eg, expanded) allelesCPT4
- 81344TBP (TATA box binding protein) (eg, spinocerebellar ataxia) gene analysis, evaluation to detect abnormal (eg, expanded) allelesCPT4
- 81346TYMS (thymidylate synthetase) (eg, 5-fluorouracil/5-FU drug metabolism), gene analysis, common variant(s) (eg, tandem repeat variant)CPT4
- 81350UGT1A1 (UDP glucuronosyltransferase 1 family, polypeptide A1) (eg, drug metabolism, hereditary unconjugated hyperbilirubinemia [Gilbert syndrome]) gene analysis, common variants (eg, *28, *36, *37)CPT4
- 81351TP53 (tumor protein 53) (eg, Li-Fraumeni syndrome) gene analysis; full gene sequenceCPT4
- 81352TP53 (tumor protein 53) (eg, Li-Fraumeni syndrome) gene analysis; targeted sequence analysis (eg, 4 oncology)CPT4
- 81355VKORC1 (vitamin K epoxide reductase complex, subunit 1) (eg, warfarin metabolism), gene analysis, common variant(s) (eg, -1639G>A, c.173+1000C>T)CPT4
- 81361HBB (hemoglobin, subunit beta) (eg, sickle cell anemia, beta thalassemia, hemoglobinopathy); common variant(s) (eg, HbS, HbC, HbE)CPT4
- 81363HBB (hemoglobin, subunit beta) (eg, sickle cell anemia, beta thalassemia, hemoglobinopathy); duplication/deletion variant(s)CPT4
- 81364HBB (hemoglobin, subunit beta) (eg, sickle cell anemia, beta thalassemia, hemoglobinopathy); full gene sequenceCPT4
- 81370HLA Class I and II typing, low resolution (eg, antigen equivalents); HLA-A, -B, -C, -DRB1/3/4/5, and -DQB1CPT4
- 81371HLA Class I and II typing, low resolution (eg, antigen equivalents); HLA-A, -B, and -DRB1 (eg, verification typing)CPT4
- 81372HLA Class I typing, low resolution (eg, antigen equivalents); complete (ie, HLA-A, -B, and -C)CPT4
- 81373HLA Class I typing, low resolution (eg, antigen equivalents); one locus (eg, HLA-A, -B, or -C), eachCPT4
- 81374HLA Class I typing, low resolution (eg, antigen equivalents); one antigen equivalent (eg, B*27), eachCPT4
- 81375HLA Class II typing, low resolution (eg, antigen equivalents); HLA-DRB1/3/4/5 and -DQB1CPT4
- 81376HLA Class II typing, low resolution (eg, antigen equivalents); one locus (eg, HLA-DRB1, -DRB3/4/5, -DQB1, -DQA1, -DPB1, or -DPA1), eachCPT4
- 81377HLA Class II typing, low resolution (eg, antigen equivalents); one antigen equivalent, eachCPT4
- 81378HLA Class I and II typing, high resolution (ie, alleles or allele groups), HLA-A, -B, -C, and -DRB1CPT4
- 81379HLA Class I typing, high resolution (ie, alleles or allele groups); complete (ie, HLA-A, -B, and -C)CPT4
- 81380HLA Class I typing, high resolution (ie, alleles or allele groups); one locus (eg, HLA-A, -B, or -C), eachCPT4
- 81381HLA Class I typing, high resolution (ie, alleles or allele groups); one allele or allele group (eg, B*57:01P), eachCPT4
- 81382HLA Class II typing, high resolution (ie, alleles or allele groups); one locus (eg, HLA-DRB1, -DRB3/4/5, -DQB1, -DQA1, -DPB1, or -DPA1), eachCPT4
- 81383HLA Class II typing, high resolution (ie, alleles or allele groups); one allele or allele group (eg, HLA-DQB1*06:02P), eachCPT4
- 81400Molecular pathology procedure, Level 1CPT4
- 81401Molecular pathology procedure, Level 2CPT4
- 81402Molecular pathology procedure, Level 3CPT4
- 81403Molecular pathology procedure, Level 4CPT4
- 81404Molecular pathology procedure, Level 5CPT4
- 81405Molecular pathology procedure, Level 6CPT4
- 81406Molecular pathology procedure, Level 7CPT4
- 81407Molecular pathology procedure, Level 8CPT4
- 81408Molecular pathology procedure, Level 9CPT4
- 81410Aortic dysfunction or dilation (eg, Marfan syndrome, Loeys Dietz syndrome, Ehler Danlos syndrome type IV, arterial tortuosity syndrome); genomic sequence analysis panel, must include sequencing of at least 9 genes, including FBN1, TGFBR1, TGFBR2, COL3A1, CPT4
- 81411Aortic dysfunction or dilation (eg, Marfan syndrome, Loeys Dietz syndrome, Ehler Danlos syndrome type IV, arterial tortuosity syndrome); duplication/deletion analysis panel, must include analyses for TGFBR1, TGFBR2, MYH11, and COL3A1CPT4
- 81412Ashkenazi Jewish associated disorders (eg, Bloom syndrome, Canavan disease, cystic fibrosis, familial dysautonomia, Fanconi anemia group C, Gaucher disease, Tay-Sachs disease), genomic sequence analysis panel, must include sequencing of at least 9 genes, CPT4
- 81413Cardiac ion channelopathies (eg, Brugada syndrome, long QT syndrome, short QT syndrome, catecholaminergic polymorphic ventricular tachycardia); genomic sequence analysis panel, must include sequencing of at least 10 genes, including ANK2, CASQ2, CAV3, KCNCPT4
- 81414Cardiac ion channelopathies (eg, Brugada syndrome, long QT syndrome, short QT syndrome, catecholaminergic polymorphic ventricular tachycardia); duplication/deletion gene analysis panel, must include analysis of at least 2 genes, including KCNH2 and KCNQ1CPT4
- 81415Exome (eg, unexplained constitutional or heritable disorder or syndrome); sequence analysisCPT4
- 81416Exome (eg, unexplained constitutional or heritable disorder or syndrome); sequence analysis, each comparator exome (eg, parents, siblings) (List separately in addition to code for primary procedure)CPT4
- 81419Epilepsy genomic sequence analysis panel, must include analyses for ALDH7A1, CACNA1A, CDKL5, CHD2, GABRG2, GRIN2A, KCNQ2, MECP2, PCDH19, POLG, PRRT2, SCN1A, SCN1B, SCN2A, SCN8A, SLC2A1, SLC9A6, STXBP1, SYNGAP1, TCF4, TPP1, TSC1, TSC2, and ZEB2CPT4
- 81420Fetal chromosomal aneuploidy (eg, trisomy 21, monosomy X) genomic sequence analysis panel, circulating cell-free fetal DNA in maternal blood, must include analysis of chromosomes 13, 18, and 21CPT4
- 81422Fetal chromosomal microdeletion(s) genomic sequence analysis (eg, DiGeorge syndrome, Cri-du-chat syndrome), circulating cell-free fetal DNA in maternal bloodCPT4
- 81425Genome (eg, unexplained constitutional or heritable disorder or syndrome); sequence analysisCPT4
- 81430Hearing loss (eg, nonsyndromic hearing loss, Usher syndrome, Pendred syndrome); genomic sequence analysis panel, must include sequencing of at least 60 genes, including CDH23, CLRN1, GJB2, GPR98, MTRNR1, MYO7A, MYO15A, PCDH15, OTOF, SLC26A4, TMC1, TMPRSS3CPT4
- 81431Hearing loss (eg, nonsyndromic hearing loss, Usher syndrome, Pendred syndrome); duplication/deletion analysis panel, must include copy number analyses for STRC and DFNB1 deletions in GJB2 and GJB6 genesCPT4
- 81432Hereditary breast cancer-related disorders (eg, hereditary breast cancer, hereditary ovarian cancer, hereditary endometrial cancer); genomic sequence analysis panel, must include sequencing of at least 10 genes, always including BRCA1, BRCA2, CDH1, MLH1, CPT4
- 81433Hereditary breast cancer-related disorders (eg, hereditary breast cancer, hereditary ovarian cancer, hereditary endometrial cancer); duplication/deletion analysis panel, must include analyses for BRCA1, BRCA2, MLH1, MSH2, and STK11CPT4
- 81434Hereditary retinal disorders (eg, retinitis pigmentosa, Leber congenital amaurosis, cone-rod dystrophy), genomic sequence analysis panel, must include sequencing of at least 15 genes, including ABCA4, CNGA1, CRB1, EYS, PDE6A, PDE6B, PRPF31, PRPH2, RDH12, CPT4
- 81435Hereditary colon cancer disorders (eg, Lynch syndrome, PTEN hamartoma syndrome, Cowden syndrome, familial adenomatosis polyposis); genomic sequence analysis panel, must include sequencing of at least 10 genes, including APC, BMPR1A, CDH1, MLH1, MSH2, MSH6CPT4
- 81436Hereditary colon cancer disorders (eg, Lynch syndrome, PTEN hamartoma syndrome, Cowden syndrome, familial adenomatosis polyposis); duplication/deletion analysis panel, must include analysis of at least 5 genes, including MLH1, MSH2, EPCAM, SMAD4, and STK1CPT4
- 81437Hereditary neuroendocrine tumor disorders (eg, medullary thyroid carcinoma, parathyroid carcinoma, malignant pheochromocytoma or paraganglioma); genomic sequence analysis panel, must include sequencing of at least 6 genes, including MAX, SDHB, SDHC, SDHD,CPT4
- 81439Hereditary cardiomyopathy (eg, hypertrophic cardiomyopathy, dilated cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy), genomic sequence analysis panel, must include sequencing of at least 5 cardiomyopathy-related genes (eg, DSG2, MYBPC3, MYCPT4
- 81440Nuclear encoded mitochondrial genes (eg, neurologic or myopathic phenotypes), genomic sequence panel, must include analysis of at least 100 genes, including BCS1L, C10orf2, COQ2, COX10, DGUOK, MPV17, OPA1, PDSS2, POLG, POLG2, RRM2B, SCO1, SCO2, SLC25A4, SCPT4
- 81442Noonan spectrum disorders (eg, Noonan syndrome, cardio-facio-cutaneous syndrome, Costello syndrome, LEOPARD syndrome, Noonan-like syndrome), genomic sequence analysis panel, must include sequencing of at least 12 genes, including BRAF, CBL, HRAS, KRAS, MACPT4
- 81443Genetic testing for severe inherited conditions (eg, cystic fibrosis, Ashkenazi Jewish-associated disorders [eg, Bloom syndrome, Canavan disease, Fanconi anemia type C, mucolipidosis type VI, Gaucher disease, Tay-Sachs disease], beta hemoglobinopathies, pCPT4
- 81445Targeted genomic sequence analysis panel, solid organ neoplasm, DNA analysis, and RNA analysis when performed, 5-50 genes (eg, ALK, BRAF, CDKN2A, EGFR, ERBB2, KIT, KRAS, NRAS, MET, PDGFRA, PDGFRB, PGR, PIK3CA, PTEN, RET), interrogation for sequence varianCPT4
- 81448Hereditary peripheral neuropathies (eg, Charcot-Marie-Tooth, spastic paraplegia), genomic sequence analysis panel, must include sequencing of at least 5 peripheral neuropathy-related genes (eg, BSCL2, GJB1, MFN2, MPZ, REEP1, SPAST, SPG11, SPTLC1)CPT4
- 81450Targeted genomic sequence analysis panel, hematolymphoid neoplasm or disorder, DNA analysis, and RNA analysis when performed, 5-50 genes (eg, BRAF, CEBPA, DNMT3A, EZH2, FLT3, IDH1, IDH2, JAK2, KRAS, KIT, MLL, NRAS, NPM1, NOTCH1), interrogation for sequencCPT4
- 81455Targeted genomic sequence analysis panel, solid organ or hematolymphoid neoplasm, DNA analysis, and RNA analysis when performed, 51 or greater genes (eg, ALK, BRAF, CDKN2A, CEBPA, DNMT3A, EGFR, ERBB2, EZH2, FLT3, IDH1, IDH2, JAK2, KIT, KRAS, MLL, NPM1, NRCPT4
- 81460Whole mitochondrial genome (eg, Leigh syndrome, mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes [MELAS], myoclonic epilepsy with ragged-red fibers [MERFF], neuropathy, ataxia, and retinitis pigmentosa [NARP], Leber hereditary opCPT4
- 81465Whole mitochondrial genome large deletion analysis panel (eg, Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia), including heteroplasmy detection, if performedCPT4
- 81470X-linked intellectual disability (XLID) (eg, syndromic and non-syndromic XLID); genomic sequence analysis panel, must include sequencing of at least 60 genes, including ARX, ATRX, CDKL5, FGD1, FMR1, HUWE1, IL1RAPL, KDM5C, L1CAM, MECP2, MED12, MID1, OCRL, CPT4
- 81471X-linked intellectual disability (XLID) (eg, syndromic and non-syndromic XLID); duplication/deletion gene analysis, must include analysis of at least 60 genes, including ARX, ATRX, CDKL5, FGD1, FMR1, HUWE1, IL1RAPL, KDM5C, L1CAM, MECP2, MED12, MID1, OCRL,CPT4
- 81479Unlisted molecular pathology procedureCPT4
- 81490Autoimmune (rheumatoid arthritis), analysis of 12 biomarkers using immunoassays, utilizing serum, prognostic algorithm reported as a disease activity scoreCPT4
- 81500Oncology (ovarian), biochemical assays of two proteins (CA-125 and HE4), utilizing serum, with menopausal status, algorithm reported as a risk scoreCPT4
- 81503Oncology (ovarian), biochemical assays of five proteins (CA-125, apolipoprotein A1, beta-2 microglobulin, transferrin, and pre-albumin), utilizing serum, algorithm reported as a risk scoreCPT4
- 81507Fetal aneuploidy (trisomy 21, 18, and 13) DNA sequence analysis of selected regions using maternal plasma, algorithm reported as a risk score for each trisomyCPT4
- 81508Fetal congenital abnormalities, biochemical assays of two proteins (PAPP-A, hCG [any form]), utilizing maternal serum, algorithm reported as a risk scoreCPT4
- 81511Fetal congenital abnormalities, biochemical assays of four analytes (AFP, uE3, hCG [any form], DIA) utilizing maternal serum, algorithm reported as a risk score (may include additional results from previous biochemical testing)CPT4
- 81512Fetal congenital abnormalities, biochemical assays of five analytes (AFP, uE3, total hCG, hyperglycosylated hCG, DIA) utilizing maternal serum, algorithm reported as a risk scoreCPT4
- 81513Infectious disease, bacterial vaginosis, quantitative real-time amplification of RNA markers for Atopobium vaginae, Gardnerella vaginalis, and Lactobacillus species, utilizing vaginal-fluid specimens, algorithm reported as a positive or negative result foCPT4
- 81514Infectious disease, bacterial vaginosis and vaginitis, quantitative real-time amplification of DNA markers for Gardnerella vaginalis, Atopobium vaginae, Megasphaera type 1, Bacterial Vaginosis Associated Bacteria-2 (BVAB-2), and Lactobacillus species (L. CPT4
- 81518Oncology (breast), mRNA, gene expression profiling by real-time RT-PCR of 11 genes (7 content and 4 housekeeping), utilizing formalin-fixed paraffin-embedded tissue, algorithms reported as percentage risk for metastatic recurrence and likelihood of benefiCPT4
- 81519Oncology (breast), mRNA, gene expression profiling by real-time RT-PCR of 21 genes, utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as recurrence scoreCPT4
- 81521Oncology (breast), mRNA, microarray gene expression profiling of 70 content genes and 465 housekeeping genes, utilizing fresh frozen or formalin-fixed paraffin-embedded tissue, algorithm reported as index related to risk of distant metastasisCPT4
- 81525Oncology (colon), mRNA, gene expression profiling by real-time RT-PCR of 12 genes (7 content and 5 housekeeping), utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as a recurrence scoreCPT4
- 81528Oncology (colorectal) screening, quantitative real-time target and signal amplification of 10 DNA markers (KRAS mutations, promoter methylation of NDRG4 and BMP3) and fecal hemoglobin, utilizing stool, algorithm reported as a positive or negative resultCPT4
- 81538Oncology (lung), mass spectrometric 8-protein signature, including amyloid A, utilizing serum, prognostic and predictive algorithm reported as good versus poor overall survivalCPT4
- 81539Oncology (high-grade prostate cancer), biochemical assay of four proteins (Total PSA, Free PSA, Intact PSA, and human kallikrein-2 [hK2]), utilizing plasma or serum, prognostic algorithm reported as a probability scoreCPT4
- 81540Oncology (tumor of unknown origin), mRNA, gene expression profiling by real-time RT-PCR of 92 genes (87 content and 5 housekeeping) to classify tumor into main cancer type and subtype, utilizing formalin-fixed paraffin-embedded tissue, algorithm reported CPT4
- 81541Oncology (prostate), mRNA gene expression profiling by real-time RT-PCR of 46 genes (31 content and 15 housekeeping), utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as a disease-specific mortality risk scoreCPT4
- 81542Oncology (prostate), mRNA, microarray gene expression profiling of 22 content genes, utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as metastasis risk scoreCPT4
- 81545Oncology (thyroid), gene expression analysis of 142 genes, utilizing fine needle aspirate, algorithm reported as a categorical result (eg, benign or suspicious)CPT4
- 81546Oncology (thyroid), mRNA, gene expression analysis of 10,196 genes, utilizing fine needle aspirate, algorithm reported as a categorical result (eg, benign or suspicious)CPT4
- 81551Oncology (prostate), promoter methylation profiling by real-time PCR of 3 genes (GSTP1, APC, RASSF1), utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as a likelihood of prostate cancer detection on repeat biopsyCPT4
- 81552Oncology (uveal melanoma), mRNA, gene expression profiling by real-time RT-PCR of 15 genes (12 content and 3 housekeeping), utilizing fine needle aspirate or formalin-fixed paraffin-embedded tissue, algorithm reported as risk of metastasisCPT4
- 81554Pulmonary disease (idiopathic pulmonary fibrosis [IPF]), mRNA, gene expression analysis of 190 genes, utilizing transbronchial biopsies, diagnostic algorithm reported as categorical result (eg, positive or negative for high probability of usual interstitiCPT4
- 81595Cardiology (heart transplant), mRNA, gene expression profiling by real-time quantitative PCR of 20 genes (11 content and 9 housekeeping), utilizing subfraction of peripheral blood, algorithm reported as a rejection risk scoreCPT4
- 81596Infectious disease, chronic hepatitis C virus (HCV) infection, six biochemical assays (ALT, A2-macroglobulin, apolipoprotein A-1, total bilirubin, GGT, and haptoglobin) utilizing serum, prognostic algorithm reported as scores for fibrosis and necroinflammCPT4
- 81599Unlisted multianalyte assay with algorithmic analysisCPT4
- 82009Ketone body(s) (eg, acetone, acetoacetic acid, beta-hydroxybutyrate); qualitativeCPT4
- 82010Ketone body(s) (eg, acetone, acetoacetic acid, beta-hydroxybutyrate); quantitativeCPT4
- 82013AcetylcholinesteraseCPT4
- 82016Acylcarnitines; qualitative, each specimenCPT4
- 82017Acylcarnitines; quantitative, each specimenCPT4
- 82024Adrenocorticotropic hormone (ACTH)CPT4
- 82040Albumin; serum, plasma or whole bloodCPT4
- 82042Albumin; other source, quantitative, each specimenCPT4
- 82043Albumin; urine (eg, microalbumin), quantitativeCPT4
- 82044Albumin; urine (eg, microalbumin), semiquantitative (eg, reagent strip assay)CPT4
- 82045Albumin; ischemia modifiedCPT4
- 82055Alcohol (ethanol); any specimen except breathCPT4
- 82075Alcohol (ethanol); breathCPT4
- 82077Alcohol (ethanol); any specimen except urine and breath, immunoassay (eg, IA, EIA, ELISA, RIA, EMIT, FPIA) and enzymatic methods (eg, alcohol dehydrogenase)CPT4
- 82085AldolaseCPT4
- 82088AldosteroneCPT4
- 82103Alpha-1-antitrypsin; totalCPT4
- 82104Alpha-1-antitrypsin; phenotypeCPT4
- 82105Alpha-fetoprotein (AFP); serumCPT4
- 82106Alpha-fetoprotein (AFP); amniotic fluidCPT4
- 82107Alpha-fetoprotein (AFP); AFP-L3 fraction isoform and total AFP (including ratio)CPT4
- 82108AluminumCPT4
- 82120Amines, vaginal fluid, qualitativeCPT4
- 82127Amino acids; single, qualitative, each specimenCPT4
- 82128Amino acids; multiple, qualitative, each specimenCPT4
- 82131Amino acids; single, quantitative, each specimenCPT4
- 82135Aminolevulinic acid, delta (ALA)CPT4
- 82136Amino acids, 2 to 5 amino acids, quantitative, each specimenCPT4
- 82139Amino acids, 6 or more amino acids, quantitative, each specimenCPT4
- 82140AmmoniaCPT4
- 82143Amniotic fluid scan (spectrophotometric)CPT4
- 82145Amphetamine or methamphetamineCPT4
- 82150AmylaseCPT4
- 82154Androstanediol glucuronideCPT4
- 82157AndrostenedioneCPT4
- 82160AndrosteroneCPT4
- 82163Angiotensin IICPT4
- 82164Angiotensin I - converting enzyme (ACE)CPT4
- 82172Apolipoprotein, eachCPT4
- 82175ArsenicCPT4
- 82180Ascorbic acid (Vitamin C), bloodCPT4
- 82190Atomic absorption spectroscopy, each analyteCPT4
- 82232Beta-2 microglobulinCPT4
- 82239Bile acids; totalCPT4
- 82240Bile acids; cholylglycineCPT4
- 82247Bilirubin; totalCPT4
- 82248Bilirubin; directCPT4
- 82261Biotinidase, each specimenCPT4
- 82270Blood, occult, by peroxidase activity (eg, guaiac), qualitative; feces, consecutive collected specimens with single determination, for colorectal neoplasm screening (ie, patient was provided 3 cards or single triple card for consecutive collection)CPT4
- 82271Blood, occult, by peroxidase activity (eg, guaiac), qualitative; other sourcesCPT4
- 82272Blood, occult, by peroxidase activity (eg, guaiac), qualitative, feces, 1-3 simultaneous determinations, performed for other than colorectal neoplasm screeningCPT4
- 82274Blood, occult, by fecal hemoglobin determination by immunoassay, qualitative, feces, 1-3 simultaneous determinationsCPT4
- 82300CadmiumCPT4
- 82306Vitamin D; 25 hydroxy, includes fraction(s), if performedCPT4
- 82308CalcitoninCPT4
- 82310Calcium; totalCPT4
- 82330Calcium; ionizedCPT4
- 82340Calcium; urine quantitative, timed specimenCPT4
- 82355Calculus; qualitative analysisCPT4
- 82360Calculus; quantitative analysis, chemicalCPT4
- 82365Calculus; infrared spectroscopyCPT4
- 82370Calculus; X-ray diffractionCPT4
- 82373Carbohydrate deficient transferrinCPT4
- 82374Carbon dioxide (bicarbonate)CPT4
- 82375Carboxyhemoglobin; quantitativeCPT4
- 82376Carboxyhemoglobin; qualitativeCPT4
- 82378Carcinoembryonic antigen (CEA)CPT4
- 82379Carnitine (total and free), quantitative, each specimenCPT4
- 82380CaroteneCPT4
- 82382Catecholamines; total urineCPT4
- 82383Catecholamines; bloodCPT4
- 82384Catecholamines; fractionatedCPT4
- 82390CeruloplasminCPT4
- 82397Chemiluminescent assayCPT4
- 82415ChloramphenicolCPT4
- 82435Chloride; bloodCPT4
- 82436Chloride; urineCPT4
- 82438Chloride; other sourceCPT4
- 82465Cholesterol, serum or whole blood, totalCPT4
- 82480Cholinesterase; serumCPT4
- 82482Cholinesterase; RBCCPT4
- 82492Chromatography, quantitative, column (eg, gas liquid or HPLC); multiple analytes, single stationary and mobile phaseCPT4
- 82495ChromiumCPT4
- 82507CitrateCPT4
- 82523Collagen cross links, any methodCPT4
- 82525CopperCPT4
- 82528CorticosteroneCPT4
- 82530Cortisol; freeCPT4
- 82533Cortisol; totalCPT4
- 82540CreatineCPT4
- 82542Column chromatography, includes mass spectrometry, if performed (eg, HPLC, LC, LC/MS, LC/MS-MS, GC, GC/MS-MS, GC/MS, HPLC/MS), non-drug analyte(s) not elsewhere specified, qualitative or quantitative, each specimenCPT4
- 82544Column chromatography/mass spectrometry (eg, GC/MS, or HPLC/MS), non-drug analyte not elsewhere specified; stable isotope dilution, multiple analytes, quantitative, single stationary and mobile phaseCPT4
- 82550Creatine kinase (CK), (CPK); totalCPT4
- 82552Creatine kinase (CK), (CPK); isoenzymesCPT4
- 82553Creatine kinase (CK), (CPK); MB fraction onlyCPT4
- 82565Creatinine; bloodCPT4
- 82570Creatinine; other sourceCPT4
- 82575Creatinine; clearanceCPT4
- 82585CryofibrinogenCPT4
- 82595Cryoglobulin, qualitative or semi-quantitative (eg, cryocrit)CPT4
- 82600CyanideCPT4
- 82607Cyanocobalamin (Vitamin B-12)CPT4
- 82608Cyanocobalamin (Vitamin B-12); unsaturated binding capacityCPT4
- 82610Cystatin CCPT4
- 82615Cystine and homocystine, urine, qualitativeCPT4
- 82626Dehydroepiandrosterone (DHEA)CPT4
- 82627Dehydroepiandrosterone-sulfate (DHEA-S)CPT4
- 82633Desoxycorticosterone, 11-CPT4
- 82634Deoxycortisol, 11-CPT4
- 82638Dibucaine numberCPT4
- 82642Dihydrotestosterone (DHT)CPT4
- 82652Vitamin D; 1, 25 dihydroxy, includes fraction(s), if performedCPT4
- 82656Elastase, pancreatic (EL-1), fecal, qualitative or semi-quantitativeCPT4
- 82657Enzyme activity in blood cells, cultured cells, or tissue, not elsewhere specified; nonradioactive substrate, each specimenCPT4
- 82658Enzyme activity in blood cells, cultured cells, or tissue, not elsewhere specified; radioactive substrate, each specimenCPT4
- 82664Electrophoretic technique, not elsewhere specifiedCPT4
- 82668ErythropoietinCPT4
- 82670Estradiol; totalCPT4
- 82671Estrogens; fractionatedCPT4
- 82672Estrogens; totalCPT4
- 82677EstriolCPT4
- 82679EstroneCPT4
- 82681Estradiol; free, direct measurement (eg, equilibrium dialysis)CPT4
- 82693Ethylene glycolCPT4
- 82696EtiocholanoloneCPT4
- 82705Fat or lipids, feces; qualitativeCPT4
- 82710Fat or lipids, feces; quantitativeCPT4
- 82715Fat differential, feces, quantitativeCPT4
- 82725Fatty acids, nonesterifiedCPT4
- 82726Very long chain fatty acidsCPT4
- 82728FerritinCPT4
- 82731Fetal fibronectin, cervicovaginal secretions, semi-quantitativeCPT4
- 82735FluorideCPT4
- 82746Folic acid; serumCPT4
- 82747Folic acid; RBCCPT4
- 82757Fructose, semenCPT4
- 82760GalactoseCPT4
- 82775Galactose-1-phosphate uridyl transferase; quantitativeCPT4
- 82777Galectin-3CPT4
- 82784Gammaglobulin (immunoglobulin); IgA, IgD, IgG, IgM, eachCPT4
- 82785Gammaglobulin (immunoglobulin); IgECPT4
- 82787Gammaglobulin (immunoglobulin); immunoglobulin subclasses (eg, IgG1, 2, 3, or 4), eachCPT4
- 82800Gases, blood, pH onlyCPT4
- 82803Gases, blood, any combination of pH, pCO2, pO2, CO2, HCO3 (including calculated O2 saturation)CPT4
- 82805Gases, blood, any combination of pH, pCO2, pO2, CO2, HCO3 (including calculated O2 saturation); with O2 saturation, by direct measurement, except pulse oximetryCPT4
- 82810Gases, blood, O2 saturation only, by direct measurement, except pulse oximetryCPT4
- 82820Hemoglobin-oxygen affinity (pO2 for 50% hemoglobin saturation with oxygen)CPT4
- 82941GastrinCPT4
- 82943GlucagonCPT4
- 82945Glucose, body fluid, other than bloodCPT4
- 82947Glucose; quantitative, blood (except reagent strip)CPT4
- 82948Glucose; blood, reagent stripCPT4
- 82950Glucose; post glucose dose (includes glucose)CPT4
- 82951Glucose; tolerance test (GTT), 3 specimens (includes glucose)CPT4
- 82952Glucose; tolerance test, each additional beyond 3 specimens (List separately in addition to code for primary procedure)CPT4
- 82955Glucose-6-phosphate dehydrogenase (G6PD); quantitativeCPT4
- 82960Glucose-6-phosphate dehydrogenase (G6PD); screenCPT4
- 82962Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home useCPT4
- 82963Glucosidase, betaCPT4
- 82965Glutamate dehydrogenaseCPT4
- 82977Glutamyltransferase, gamma (GGT)CPT4
- 82978GlutathioneCPT4
- 82985Glycated proteinCPT4
- 83001Gonadotropin; follicle stimulating hormone (FSH)CPT4
- 83002Gonadotropin; luteinizing hormone (LH)CPT4
- 83003Growth hormone, human (HGH) (somatotropin)CPT4
- 83006Growth stimulation expressed gene 2 (ST2, Interleukin 1 receptor like-1)CPT4
- 83009Helicobacter pylori, blood test analysis for urease activity, non-radioactive isotope (eg, C-13)CPT4
- 83010Haptoglobin; quantitativeCPT4
- 83013Helicobacter pylori; breath test analysis for urease activity, non-radioactive isotope (eg, C-13)CPT4
- 83014Helicobacter pylori; drug administrationCPT4
- 83015Heavy metal (eg, arsenic, barium, beryllium, bismuth, antimony, mercury); qualitative, any number of analytesCPT4
- 83018Heavy metal (eg, arsenic, barium, beryllium, bismuth, antimony, mercury); quantitative, each, not elsewhere specifiedCPT4
- 83020Hemoglobin fractionation and quantitation; electrophoresis (eg, A2, S, C, and/or F)CPT4
- 83021Hemoglobin fractionation and quantitation; chromatography (eg, A2, S, C, and/or F)CPT4
- 83026Hemoglobin; by copper sulfate method, non-automatedCPT4
- 83030Hemoglobin; F (fetal), chemicalCPT4
- 83036Hemoglobin; glycosylated (A1C)CPT4
- 83037Hemoglobin; glycosylated (A1C) by device cleared by FDA for home useCPT4
- 83045Hemoglobin; methemoglobin, qualitativeCPT4
- 83050Hemoglobin; methemoglobin, quantitativeCPT4
- 83051Hemoglobin; plasmaCPT4
- 83060Hemoglobin; sulfhemoglobin, quantitativeCPT4
- 83068Hemoglobin; unstable, screenCPT4
- 83069Hemoglobin; urineCPT4
- 83070Hemosiderin, qualitativeCPT4
- 83080b-Hexosaminidase, each assayCPT4
- 83088HistamineCPT4
- 83090HomocysteineCPT4
- 83150Homovanillic acid (HVA)CPT4
- 83491Hydroxycorticosteroids, 17- (17-OHCS)CPT4
- 83497Hydroxyindolacetic acid, 5-(HIAA)CPT4
- 83498Hydroxyprogesterone, 17-dCPT4
- 83505Hydroxyproline; totalCPT4
- 83516Immunoassay for analyte other than infectious agent antibody or infectious agent antigen; qualitative or semiquantitative, multiple step methodCPT4
- 83518Immunoassay for analyte other than infectious agent antibody or infectious agent antigen; qualitative or semiquantitative, single step method (eg, reagent strip)CPT4
- 83519Immunoassay for analyte other than infectious agent antibody or infectious agent antigen; quantitative, by radioimmunoassay (eg, RIA)CPT4
- 83520Immunoassay for analyte other than infectious agent antibody or infectious agent antigen; quantitative, not otherwise specifiedCPT4
- 83525Insulin; totalCPT4
- 83527Insulin; freeCPT4
- 83540IronCPT4
- 83550Iron binding capacityCPT4
- 83570Isocitric dehydrogenase (IDH)CPT4
- 83586Ketosteroids, 17- (17-KS); totalCPT4
- 83593Ketosteroids, 17- (17-KS); fractionationCPT4
- 83605Lactate (lactic acid)CPT4
- 83615Lactate dehydrogenase (LD), (LDH)CPT4
- 83625Lactate dehydrogenase (LD), (LDH); isoenzymes, separation and quantitationCPT4
- 83630Lactoferrin, fecal; qualitativeCPT4
- 83631Lactoferrin, fecal; quantitativeCPT4
- 83655LeadCPT4
- 83664Fetal lung maturity assessment; lamellar body densityCPT4
- 83690LipaseCPT4
- 83695Lipoprotein (a)CPT4
- 83698Lipoprotein-associated phospholipase A2 (Lp-PLA2)CPT4
- 83700Lipoprotein, blood; electrophoretic separation and quantitationCPT4
- 83701Lipoprotein, blood; high resolution fractionation and quantitation of lipoproteins including lipoprotein subclasses when performed (eg, electrophoresis, ultracentrifugation)CPT4
- 83704Lipoprotein, blood; quantitation of lipoprotein particle number(s) (eg, by nuclear magnetic resonance spectroscopy), includes lipoprotein particle subclass(es), when performedCPT4
- 83718Lipoprotein, direct measurement; high density cholesterol (HDL cholesterol)CPT4
- 83719Lipoprotein, direct measurement; VLDL cholesterolCPT4
- 83721Lipoprotein, direct measurement; LDL cholesterolCPT4
- 83722Lipoprotein, direct measurement; small dense LDL cholesterolCPT4
- 83735MagnesiumCPT4
- 83785ManganeseCPT4
- 83789Mass spectrometry and tandem mass spectrometry (eg, MS, MS/MS, MALDI, MS-TOF, QTOF), non-drug analyte(s) not elsewhere specified, qualitative or quantitative, each specimenCPT4
- 83825Mercury, quantitativeCPT4
- 83835MetanephrinesCPT4
- 83861Microfluidic analysis utilizing an integrated collection and analysis device, tear osmolarityCPT4
- 83864Mucopolysaccharides, acid, quantitativeCPT4
- 83872Mucin, synovial fluid (Ropes test)CPT4
- 83873Myelin basic protein, cerebrospinal fluidCPT4
- 83874MyoglobinCPT4
- 83876Myeloperoxidase (MPO)CPT4
- 83880Natriuretic peptideCPT4
- 83883Nephelometry, each analyte not elsewhere specifiedCPT4
- 83885NickelCPT4
- 83915Nucleotidase 5'-CPT4
- 83916Oligoclonal immune (oligoclonal bands)CPT4
- 83918Organic acids; total, quantitative, each specimenCPT4
- 83919Organic acids; qualitative, each specimenCPT4
- 83921Organic acid, single, quantitativeCPT4
- 83925Opiate(s), drug and metabolites, each procedureCPT4
- 83930Osmolality; bloodCPT4
- 83935Osmolality; urineCPT4
- 83937Osteocalcin (bone g1a protein)CPT4
- 83945OxalateCPT4
- 83951Oncoprotein; des-gamma-carboxy-prothrombin (DCP)CPT4
- 83970Parathormone (parathyroid hormone)CPT4
- 83986pH; body fluid, not otherwise specifiedCPT4
- 83992Phencyclidine (PCP)CPT4
- 83993Calprotectin, fecalCPT4
- 84030Phenylalanine (PKU), bloodCPT4
- 84035Phenylketones, qualitativeCPT4
- 84060Phosphatase, acid; totalCPT4
- 84066Phosphatase, acid; prostaticCPT4
- 84075Phosphatase, alkalineCPT4
- 84078Phosphatase, alkaline; heat stable (total not included)CPT4
- 84080Phosphatase, alkaline; isoenzymesCPT4
- 84081PhosphatidylglycerolCPT4
- 84085Phosphogluconate, 6-, dehydrogenase, RBCCPT4
- 84087Phosphohexose isomeraseCPT4
- 84100Phosphorus inorganic (phosphate)CPT4
- 84105Phosphorus inorganic (phosphate); urineCPT4
- 84106Porphobilinogen, urine; qualitativeCPT4
- 84110Porphobilinogen, urine; quantitativeCPT4
- 84112Evaluation of cervicovaginal fluid for specific amniotic fluid protein(s) (eg, placental alpha microglobulin-1 [PAMG-1], placental protein 12 [PP12], alpha-fetoprotein), qualitative, each specimenCPT4
- 84120Porphyrins, urine; quantitation and fractionationCPT4
- 84126Porphyrins, feces, quantitativeCPT4
- 84132Potassium; serum, plasma or whole bloodCPT4
- 84133Potassium; urineCPT4
- 84134PrealbuminCPT4
- 84135PregnanediolCPT4
- 84140PregnenoloneCPT4
- 8414317-hydroxypregnenoloneCPT4
- 84144ProgesteroneCPT4
- 84145Procalcitonin (PCT)CPT4
- 84146ProlactinCPT4
- 84150Prostaglandin, eachCPT4
- 84152Prostate specific antigen (PSA); complexed (direct measurement)CPT4
- 84153Prostate specific antigen (PSA); totalCPT4
- 84154Prostate specific antigen (PSA); freeCPT4
- 84155Protein, total, except by refractometry; serum, plasma or whole bloodCPT4
- 84156Protein, total, except by refractometry; urineCPT4
- 84157Protein, total, except by refractometry; other source (eg, synovial fluid, cerebrospinal fluid)CPT4
- 84160Protein, total, by refractometry, any sourceCPT4
- 84163Pregnancy-associated plasma protein-A (PAPP-A)CPT4
- 84165Protein; electrophoretic fractionation and quantitation, serumCPT4
- 84166Protein; electrophoretic fractionation and quantitation, other fluids with concentration (eg, urine, CSF)CPT4
- 84181Protein; Western Blot, with interpretation and report, blood or other body fluidCPT4
- 84182Protein; Western Blot, with interpretation and report, blood or other body fluid, immunological probe for band identification, eachCPT4
- 84202Protoporphyrin, RBC; quantitativeCPT4
- 84203Protoporphyrin, RBC; screenCPT4
- 84206ProinsulinCPT4
- 84207Pyridoxal phosphate (Vitamin B-6)CPT4
- 84210PyruvateCPT4
- 84220Pyruvate kinaseCPT4
- 84228QuinineCPT4
- 84233Receptor assay; estrogenCPT4
- 84235Receptor assay; endocrine, other than estrogen or progesterone (specify hormone)CPT4
- 84238Receptor assay; non-endocrine (specify receptor)CPT4
- 84244ReninCPT4
- 84252Riboflavin (Vitamin B-2)CPT4
- 84255SeleniumCPT4
- 84260SerotoninCPT4
- 84270Sex hormone binding globulin (SHBG)CPT4
- 84275Sialic acidCPT4
- 84295Sodium; serum, plasma or whole bloodCPT4
- 84300Sodium; urineCPT4
- 84302Sodium; other sourceCPT4
- 84305SomatomedinCPT4
- 84307SomatostatinCPT4
- 84311Spectrophotometry, analyte not elsewhere specifiedCPT4
- 84315Specific gravity (except urine)CPT4
- 84375Sugars, chromatographic, TLC or paper chromatographyCPT4
- 84376Sugars (mono-, di-, and oligosaccharides); single qualitative, each specimenCPT4
- 84377Sugars (mono-, di-, and oligosaccharides); multiple qualitative, each specimenCPT4
- 84378Sugars (mono-, di-, and oligosaccharides); single quantitative, each specimenCPT4
- 84392Sulfate, urineCPT4
- 84402Testosterone; freeCPT4
- 84403Testosterone; totalCPT4
- 84410Testosterone; bioavailable, direct measurement (eg, differential precipitation)CPT4
- 84425Thiamine (Vitamin B-1)CPT4
- 84431Thromboxane metabolite(s), including thromboxane if performed, urineCPT4
- 84432ThyroglobulinCPT4
- 84436Thyroxine; totalCPT4
- 84437Thyroxine; requiring elution (eg, neonatal)CPT4
- 84439Thyroxine; freeCPT4
- 84442Thyroxine binding globulin (TBG)CPT4
- 84443Thyroid stimulating hormone (TSH)CPT4
- 84445Thyroid stimulating immune globulins (TSI)CPT4
- 84446Tocopherol alpha (Vitamin E)CPT4
- 84449Transcortin (cortisol binding globulin)CPT4
- 84450Transferase; aspartate amino (AST) (SGOT)CPT4
- 84460Transferase; alanine amino (ALT) (SGPT)CPT4
- 84466TransferrinCPT4
- 84478TriglyceridesCPT4
- 84479Thyroid hormone (T3 or T4) uptake or thyroid hormone binding ratio (THBR)CPT4
- 84480Triiodothyronine T3; total (TT-3)CPT4
- 84481Triiodothyronine T3; freeCPT4
- 84482Triiodothyronine T3; reverseCPT4
- 84484Troponin, quantitativeCPT4
- 84488Trypsin; feces, qualitativeCPT4
- 84490Trypsin; feces, quantitative, 24-hour collectionCPT4
- 84510TyrosineCPT4
- 84512Troponin, qualitativeCPT4
- 84520Urea nitrogen; quantitativeCPT4
- 84525Urea nitrogen; semiquantitative (eg, reagent strip test)CPT4
- 84540Urea nitrogen, urineCPT4
- 84545Urea nitrogen, clearanceCPT4
- 84550Uric acid; bloodCPT4
- 84560Uric acid; other sourceCPT4
- 84585Vanillylmandelic acid (VMA), urineCPT4
- 84586Vasoactive intestinal peptide (VIP)CPT4
- 84588Vasopressin (antidiuretic hormone, ADH)CPT4
- 84590Vitamin ACPT4
- 84591Vitamin, not otherwise specifiedCPT4
- 84597Vitamin KCPT4
- 84600Volatiles (eg, acetic anhydride, diethylether)CPT4
- 84620Xylose absorption test, blood and/or urineCPT4
- 84630ZincCPT4
- 84681C-peptideCPT4
- 84702Gonadotropin, chorionic (hCG); quantitativeCPT4
- 84703Gonadotropin, chorionic (hCG); qualitativeCPT4
- 84704Gonadotropin, chorionic (hCG); free beta chainCPT4
- 84999Unlisted chemistry procedureCPT4
- 85002Bleeding timeCPT4
- 85004Blood count; automated differential WBC countCPT4
- 85007Blood count; blood smear, microscopic examination with manual differential WBC countCPT4
- 85008Blood count; blood smear, microscopic examination without manual differential WBC countCPT4
- 85009Blood count; manual differential WBC count, buffy coatCPT4
- 85013Blood count; spun microhematocritCPT4
- 85014Blood count; hematocrit (Hct)CPT4
- 85018Blood count; hemoglobin (Hgb)CPT4
- 85025Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC countCPT4
- 85027Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count)CPT4
- 85032Blood count; manual cell count (erythrocyte, leukocyte, or platelet) eachCPT4
- 85041Blood count; red blood cell (RBC), automatedCPT4
- 85044Blood count; reticulocyte, manualCPT4
- 85045Blood count; reticulocyte, automatedCPT4
- 85046Blood count; reticulocytes, automated, including 1 or more cellular parameters (eg, reticulocyte hemoglobin content [CHr], immature reticulocyte fraction [IRF], reticulocyte volume [MRV], RNA content), direct measurementCPT4
- 85048Blood count; leukocyte (WBC), automatedCPT4
- 85049Blood count; platelet, automatedCPT4
- 85055Reticulated platelet assayCPT4
- 85060Blood smear, peripheral, interpretation by physician with written reportCPT4
- 85097Bone marrow, smear interpretationCPT4
- 85130Chromogenic substrate assayCPT4
- 85175Clot lysis time, whole blood dilutionCPT4
- 85210Clotting; factor II, prothrombin, specificCPT4
- 85220Clotting; factor V (AcG or proaccelerin), labile factorCPT4
- 85230Clotting; factor VII (proconvertin, stable factor)CPT4
- 85240Clotting; factor VIII (AHG), 1-stageCPT4
- 85244Clotting; factor VIII related antigenCPT4
- 85245Clotting; factor VIII, VW factor, ristocetin cofactorCPT4
- 85246Clotting; factor VIII, VW factor antigenCPT4
- 85247Clotting; factor VIII, von Willebrand factor, multimetric analysisCPT4
- 85250Clotting; factor IX (PTC or Christmas)CPT4
- 85260Clotting; factor X (Stuart-Prower)CPT4
- 85270Clotting; factor XI (PTA)CPT4
- 85280Clotting; factor XII (Hageman)CPT4
- 85290Clotting; factor XIII (fibrin stabilizing)CPT4
- 85291Clotting; factor XIII (fibrin stabilizing), screen solubilityCPT4
- 85292Clotting; prekallikrein assay (Fletcher factor assay)CPT4
- 85293Clotting; high molecular weight kininogen assay (Fitzgerald factor assay)CPT4
- 85300Clotting inhibitors or anticoagulants; antithrombin III, activityCPT4
- 85301Clotting inhibitors or anticoagulants; antithrombin III, antigen assayCPT4
- 85302Clotting inhibitors or anticoagulants; protein C, antigenCPT4
- 85303Clotting inhibitors or anticoagulants; protein C, activityCPT4
- 85305Clotting inhibitors or anticoagulants; protein S, totalCPT4
- 85306Clotting inhibitors or anticoagulants; protein S, freeCPT4
- 85307Activated Protein C (APC) resistance assayCPT4
- 85335Factor inhibitor testCPT4
- 85347Coagulation time; activatedCPT4
- 85360Euglobulin lysisCPT4
- 85362Fibrin(ogen) degradation (split) products (FDP) (FSP); agglutination slide, semiquantitativeCPT4
- 85366Fibrin(ogen) degradation (split) products (FDP) (FSP); paracoagulationCPT4
- 85370Fibrin(ogen) degradation (split) products (FDP) (FSP); quantitativeCPT4
- 85378Fibrin degradation products, D-dimer; qualitative or semiquantitativeCPT4
- 85379Fibrin degradation products, D-dimer; quantitativeCPT4
- 85380Fibrin degradation products, D-dimer; ultrasensitive (eg, for evaluation for venous thromboembolism), qualitative or semiquantitativeCPT4
- 85384Fibrinogen; activityCPT4
- 85385Fibrinogen; antigenCPT4
- 85390Fibrinolysins or coagulopathy screen, interpretation and reportCPT4
- 85396Coagulation/fibrinolysis assay, whole blood (eg, viscoelastic clot assessment), including use of any pharmacologic additive(s), as indicated, including interpretation and written report, per dayCPT4
- 85397Coagulation and fibrinolysis, functional activity, not otherwise specified (eg, ADAMTS-13), each analyteCPT4
- 85410Fibrinolytic factors and inhibitors; alpha-2 antiplasminCPT4
- 85415Fibrinolytic factors and inhibitors; plasminogen activatorCPT4
- 85420Fibrinolytic factors and inhibitors; plasminogen, except antigenic assayCPT4
- 85441Heinz bodies; directCPT4
- 85460Hemoglobin or RBCs, fetal, for fetomaternal hemorrhage; differential lysis (Kleihauer-Betke)CPT4
- 85461Hemoglobin or RBCs, fetal, for fetomaternal hemorrhage; rosetteCPT4
- 85520Heparin assayCPT4
- 85525Heparin neutralizationCPT4
- 85530Heparin-protamine tolerance testCPT4
- 85540Leukocyte alkaline phosphatase with countCPT4
- 85549MuramidaseCPT4
- 85555Osmotic fragility, RBC; unincubatedCPT4
- 85557Osmotic fragility, RBC; incubatedCPT4
- 85576Platelet, aggregation (in vitro), each agentCPT4
- 85597Phospholipid neutralization; plateletCPT4
- 85598Phospholipid neutralization; hexagonal phospholipidCPT4
- 85610Prothrombin timeCPT4
- 85611Prothrombin time; substitution, plasma fractions, eachCPT4
- 85612Russell viper venom time (includes venom); undilutedCPT4
- 85613Russell viper venom time (includes venom); dilutedCPT4
- 85635Reptilase testCPT4
- 85651Sedimentation rate, erythrocyte; non-automatedCPT4
- 85652Sedimentation rate, erythrocyte; automatedCPT4
- 85660Sickling of RBC, reductionCPT4
- 85670Thrombin time; plasmaCPT4
- 85705Thromboplastin inhibition, tissueCPT4
- 85730Thromboplastin time, partial (PTT); plasma or whole bloodCPT4
- 85732Thromboplastin time, partial (PTT); substitution, plasma fractions, eachCPT4
- 85810ViscosityCPT4
- 85999Unlisted hematology and coagulation procedureCPT4
- 86000Agglutinins, febrile (eg, Brucella, Francisella, Murine typhus, Q fever, Rocky Mountain spotted fever, scrub typhus), each antigenCPT4
- 86001Allergen specific IgG quantitative or semiquantitative, each allergenCPT4
- 86003Allergen specific IgE; quantitative or semiquantitative, crude allergen extract, eachCPT4
- 86005Allergen specific IgE; qualitative, multiallergen screen (eg, disk, sponge, card)CPT4
- 86008Allergen specific IgE; quantitative or semiquantitative, recombinant or purified component, eachCPT4
- 86021Antibody identification; leukocyte antibodiesCPT4
- 86022Antibody identification; platelet antibodiesCPT4
- 86023Antibody identification; platelet associated immunoglobulin assayCPT4
- 86038Antinuclear antibodies (ANA)CPT4
- 86039Antinuclear antibodies (ANA); titerCPT4
- 86060Antistreptolysin 0; titerCPT4
- 86063Antistreptolysin 0; screenCPT4
- 86077Blood bank physician services; difficult cross match and/or evaluation of irregular antibody(s), interpretation and written reportCPT4
- 86078Blood bank physician services; investigation of transfusion reaction including suspicion of transmissible disease, interpretation and written reportCPT4
- 86079Blood bank physician services; authorization for deviation from standard blood banking procedures (eg, use of outdated blood, transfusion of Rh incompatible units), with written reportCPT4
- 86140C-reactive proteinCPT4
- 86141C-reactive protein; high sensitivity (hsCRP)CPT4
- 86146Beta 2 Glycoprotein I antibody, eachCPT4
- 86147Cardiolipin (phospholipid) antibody, each Ig classCPT4
- 86148Anti-phosphatidylserine (phospholipid) antibodyCPT4
- 86153Cell enumeration using immunologic selection and identification in fluid specimen (eg, circulating tumor cells in blood); physician interpretation and report, when requiredCPT4
- 86156Cold agglutinin; screenCPT4
- 86157Cold agglutinin; titerCPT4
- 86160Complement; antigen, each componentCPT4
- 86161Complement; functional activity, each componentCPT4
- 86162Complement; total hemolytic (CH50)CPT4
- 86171Complement fixation tests, each antigenCPT4
- 86200Cyclic citrullinated peptide (CCP), antibodyCPT4
- 86215Deoxyribonuclease, antibodyCPT4
- 86225Deoxyribonucleic acid (DNA) antibody; native or double strandedCPT4
- 86226Deoxyribonucleic acid (DNA) antibody; single strandedCPT4
- 86235Extractable nuclear antigen, antibody to, any method (eg, nRNP, SS-A, SS-B, Sm, RNP, Sc170, J01), each antibodyCPT4
- 86255Fluorescent noninfectious agent antibody; screen, each antibodyCPT4
- 86256Fluorescent noninfectious agent antibody; titer, each antibodyCPT4
- 86280Hemagglutination inhibition test (HAI)CPT4
- 86294Immunoassay for tumor antigen, qualitative or semiquantitative (eg, bladder tumor antigen)CPT4
- 86300Immunoassay for tumor antigen, quantitative; CA 15-3 (27.29)CPT4
- 86301Immunoassay for tumor antigen, quantitative; CA 19-9CPT4
- 86304Immunoassay for tumor antigen, quantitative; CA 125CPT4
- 86305Human epididymis protein 4 (HE4)CPT4
- 86308Heterophile antibodies; screeningCPT4
- 86309Heterophile antibodies; titerCPT4
- 86316Immunoassay for tumor antigen, other antigen, quantitative (eg, CA 50, 72-4, 549), eachCPT4
- 86317Immunoassay for infectious agent antibody, quantitative, not otherwise specifiedCPT4
- 86318Immunoassay for infectious agent antibody(ies), qualitative or semiquantitative, single-step method (eg, reagent strip)CPT4
- 86320Immunoelectrophoresis; serumCPT4
- 86325Immunoelectrophoresis; other fluids (eg, urine, cerebrospinal fluid) with concentrationCPT4
- 86328Immunoassay for infectious agent antibody(ies), qualitative or semiquantitative, single-step method (eg, reagent strip); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19])CPT4
- 86329Immunodiffusion; not elsewhere specifiedCPT4
- 86331Immunodiffusion; gel diffusion, qualitative (Ouchterlony), each antigen or antibodyCPT4
- 86332Immune complex assayCPT4
- 86334Immunofixation electrophoresis; serumCPT4
- 86335Immunofixation electrophoresis; other fluids with concentration (eg, urine, CSF)CPT4
- 86336Inhibin ACPT4
- 86337Insulin antibodiesCPT4
- 86340Intrinsic factor antibodiesCPT4
- 86341Islet cell antibodyCPT4
- 86343Leukocyte histamine release test (LHR)CPT4
- 86344Leukocyte phagocytosisCPT4
- 86352Cellular function assay involving stimulation (eg, mitogen or antigen) and detection of biomarker (eg, ATP)CPT4
- 86353Lymphocyte transformation, mitogen (phytomitogen) or antigen induced blastogenesisCPT4
- 86355B cells, total countCPT4
- 86356Mononuclear cell antigen, quantitative (eg, flow cytometry), not otherwise specified, each antigenCPT4
- 86357Natural killer (NK) cells, total countCPT4
- 86359T cells; total countCPT4
- 86360T cells; absolute CD4 and CD8 count, including ratioCPT4
- 86361T cells; absolute CD4 countCPT4
- 86367Stem cells (ie, CD34), total countCPT4
- 86376Microsomal antibodies (eg, thyroid or liver-kidney), eachCPT4
- 86382Neutralization test, viralCPT4
- 86384Nitroblue tetrazolium dye test (NTD)CPT4
- 86386Nuclear Matrix Protein 22 (NMP22), qualitativeCPT4
- 86403Particle agglutination; screen, each antibodyCPT4
- 86406Particle agglutination; titer, each antibodyCPT4
- 86430Rheumatoid factor; qualitativeCPT4
- 86431Rheumatoid factor; quantitativeCPT4
- 86480Tuberculosis test, cell mediated immunity antigen response measurement; gamma interferonCPT4
- 86481Tuberculosis test, cell mediated immunity antigen response measurement; enumeration of gamma interferon-producing T-cells in cell suspensionCPT4
- 86485Skin test; candidaCPT4
- 86510Skin test; histoplasmosisCPT4
- 86580Skin test; tuberculosis, intradermalCPT4
- 86592Syphilis test, non-treponemal antibody; qualitative (eg, VDRL, RPR, ART)CPT4
- 86593Syphilis test, non-treponemal antibody; quantitativeCPT4
- 86602Antibody; actinomycesCPT4
- 86603Antibody; adenovirusCPT4
- 86606Antibody; AspergillusCPT4
- 86609Antibody; bacterium, not elsewhere specifiedCPT4
- 86611Antibody; BartonellaCPT4
- 86612Antibody; BlastomycesCPT4
- 86615Antibody; BordetellaCPT4
- 86617Antibody; Borrelia burgdorferi (Lyme disease) confirmatory test (eg, Western Blot or immunoblot)CPT4
- 86618Antibody; Borrelia burgdorferi (Lyme disease)CPT4
- 86619Antibody; Borrelia (relapsing fever)CPT4
- 86622Antibody; BrucellaCPT4
- 86625Antibody; CampylobacterCPT4
- 86628Antibody; CandidaCPT4
- 86631Antibody; ChlamydiaCPT4
- 86632Antibody; Chlamydia, IgMCPT4
- 86635Antibody; CoccidioidesCPT4
- 86638Antibody; Coxiella burnetii (Q fever)CPT4
- 86641Antibody; CryptococcusCPT4
- 86644Antibody; cytomegalovirus (CMV)CPT4
- 86645Antibody; cytomegalovirus (CMV), IgMCPT4
- 86648Antibody; DiphtheriaCPT4
- 86651Antibody; encephalitis, California (La Crosse)CPT4
- 86652Antibody; encephalitis, Eastern equineCPT4
- 86653Antibody; encephalitis, St. LouisCPT4
- 86654Antibody; encephalitis, Western equineCPT4
- 86658Antibody; enterovirus (eg, coxsackie, echo, polio)CPT4
- 86663Antibody; Epstein-Barr (EB) virus, early antigen (EA)CPT4
- 86664Antibody; Epstein-Barr (EB) virus, nuclear antigen (EBNA)CPT4
- 86665Antibody; Epstein-Barr (EB) virus, viral capsid (VCA)CPT4
- 86666Antibody; EhrlichiaCPT4
- 86668Antibody; Francisella tularensisCPT4
- 86671Antibody; fungus, not elsewhere specifiedCPT4
- 86674Antibody; Giardia lambliaCPT4
- 86677Antibody; Helicobacter pyloriCPT4
- 86682Antibody; helminth, not elsewhere specifiedCPT4
- 86684Antibody; Haemophilus influenzaCPT4
- 86687Antibody; HTLV-ICPT4
- 86688Antibody; HTLV-IICPT4
- 86689Antibody; HTLV or HIV antibody, confirmatory test (eg, Western Blot)CPT4
- 86692Antibody; hepatitis, delta agentCPT4
- 86694Antibody; herpes simplex, non-specific type testCPT4
- 86695Antibody; herpes simplex, type 1CPT4
- 86696Antibody; herpes simplex, type 2CPT4
- 86698Antibody; histoplasmaCPT4
- 86701Antibody; HIV-1CPT4
- 86702Antibody; HIV-2CPT4
- 86703Antibody; HIV-1 and HIV-2, single resultCPT4
- 86704Hepatitis B core antibody (HBcAb); totalCPT4
- 86705Hepatitis B core antibody (HBcAb); IgM antibodyCPT4
- 86706Hepatitis B surface antibody (HBsAb)CPT4
- 86707Hepatitis Be antibody (HBeAb)CPT4
- 86708Hepatitis A antibody (HAAb)CPT4
- 86709Hepatitis A antibody (HAAb), IgM antibodyCPT4
- 86710Antibody; influenza virusCPT4
- 86711Antibody; JC (John Cunningham) virusCPT4
- 86713Antibody; LegionellaCPT4
- 86717Antibody; LeishmaniaCPT4
- 86720Antibody; LeptospiraCPT4
- 86723Antibody; Listeria monocytogenesCPT4
- 86727Antibody; lymphocytic choriomeningitisCPT4
- 86735Antibody; mumpsCPT4
- 86738Antibody; mycoplasmaCPT4
- 86741Antibody; Neisseria meningitidisCPT4
- 86744Antibody; NocardiaCPT4
- 86747Antibody; parvovirusCPT4
- 86750Antibody; Plasmodium (malaria)CPT4
- 86753Antibody; protozoa, not elsewhere specifiedCPT4
- 86756Antibody; respiratory syncytial virusCPT4
- 86757Antibody; RickettsiaCPT4
- 86759Antibody; rotavirusCPT4
- 86762Antibody; rubellaCPT4
- 86765Antibody; rubeolaCPT4
- 86768Antibody; SalmonellaCPT4
- 86769Antibody; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19])CPT4
- 86774Antibody; tetanusCPT4
- 86777Antibody; ToxoplasmaCPT4
- 86778Antibody; Toxoplasma, IgMCPT4
- 86780Antibody; Treponema pallidumCPT4
- 86784Antibody; TrichinellaCPT4
- 86787Antibody; varicella-zosterCPT4
- 86788Antibody; West Nile virus, IgMCPT4
- 86789Antibody; West Nile virusCPT4
- 86790Antibody; virus, not elsewhere specifiedCPT4
- 86793Antibody; YersiniaCPT4
- 86794Antibody; Zika virus, IgMCPT4
- 86800Thyroglobulin antibodyCPT4
- 86803Hepatitis C antibodyCPT4
- 86804Hepatitis C antibody; confirmatory test (eg, immunoblot)CPT4
- 86805Lymphocytotoxicity assay, visual crossmatch; with titrationCPT4
- 86807Serum screening for cytotoxic percent reactive antibody (PRA); standard methodCPT4
- 86812HLA typing; A, B, or C (eg, A10, B7, B27), single antigenCPT4
- 86813HLA typing; A, B, or C, multiple antigensCPT4
- 86816HLA typing; DR/DQ, single antigenCPT4
- 86817HLA typing; DR/DQ, multiple antigensCPT4
- 86821HLA typing; lymphocyte culture, mixed (MLC)CPT4
- 86825Human leukocyte antigen (HLA) crossmatch, non-cytotoxic (eg, using flow cytometry); first serum sample or dilutionCPT4
- 86826Human leukocyte antigen (HLA) crossmatch, non-cytotoxic (eg, using flow cytometry); each additional serum sample or sample dilution (List separately in addition to primary procedure)CPT4
- 86828Antibody to human leukocyte antigens (HLA), solid phase assays (eg, microspheres or beads, ELISA, flow cytometry); qualitative assessment of the presence or absence of antibody(ies) to HLA Class I and Class II HLA antigensCPT4
- 86829Antibody to human leukocyte antigens (HLA), solid phase assays (eg, microspheres or beads, ELISA, Flow cytometry); qualitative assessment of the presence or absence of antibody(ies) to HLA Class I or Class II HLA antigensCPT4
- 86830Antibody to human leukocyte antigens (HLA), solid phase assays (eg, microspheres or beads, ELISA, Flow cytometry); antibody identification by qualitative panel using complete HLA phenotypes, HLA Class ICPT4
- 86831Antibody to human leukocyte antigens (HLA), solid phase assays (eg, microspheres or beads, ELISA, Flow cytometry); antibody identification by qualitative panel using complete HLA phenotypes, HLA Class IICPT4
- 86832Antibody to human leukocyte antigens (HLA), solid phase assays (eg, microspheres or beads, ELISA, Flow cytometry); high definition qualitative panel for identification of antibody specificities (eg, individual antigen per bead methodology), HLA Class ICPT4
- 86833Antibody to human leukocyte antigens (HLA), solid phase assays (eg, microspheres or beads, ELISA, Flow cytometry); high definition qualitative panel for identification of antibody specificities (eg, individual antigen per bead methodology), HLA Class IICPT4
- 86834Antibody to human leukocyte antigens (HLA), solid phase assays (eg, microspheres or beads, ELISA, Flow cytometry); semi-quantitative panel (eg, titer), HLA Class ICPT4
- 86835Antibody to human leukocyte antigens (HLA), solid phase assays (eg, microspheres or beads, ELISA, Flow cytometry); semi-quantitative panel (eg, titer), HLA Class IICPT4
- 86849Unlisted immunology procedureCPT4
- 86850Antibody screen, RBC, each serum techniqueCPT4
- 86860Antibody elution (RBC), each elutionCPT4
- 86870Antibody identification, RBC antibodies, each panel for each serum techniqueCPT4
- 86880Antihuman globulin test (Coombs test); direct, each antiserumCPT4
- 86885Antihuman globulin test (Coombs test); indirect, qualitative, each reagent red cellCPT4
- 86886Antihuman globulin test (Coombs test); indirect, each antibody titerCPT4
- 86890Autologous blood or component, collection processing and storage; predepositedCPT4
- 86891Autologous blood or component, collection processing and storage; intra- or postoperative salvageCPT4
- 86900Blood typing, serologic; ABOCPT4
- 86901Blood typing, serologic; Rh (D)CPT4
- 86902Blood typing, serologic; antigen testing of donor blood using reagent serum, each antigen testCPT4
- 86904Blood typing, serologic; antigen screening for compatible unit using patient serum, per unit screenedCPT4
- 86905Blood typing, serologic; RBC antigens, other than ABO or Rh (D), eachCPT4
- 86906Blood typing, serologic; Rh phenotyping, completeCPT4
- 86910Blood typing, for paternity testing, per individual; ABO, Rh and MNCPT4
- 86920Compatibility test each unit; immediate spin techniqueCPT4
- 86921Compatibility test each unit; incubation techniqueCPT4
- 86922Compatibility test each unit; antiglobulin techniqueCPT4
- 86923Compatibility test each unit; electronicCPT4
- 86927Fresh frozen plasma, thawing, each unitCPT4
- 86930Frozen blood, each unit; freezing (includes preparation)CPT4
- 86932Frozen blood, each unit; freezing (includes preparation) and thawingCPT4
- 86940Hemolysins and agglutinins; auto, screen, eachCPT4
- 86941Hemolysins and agglutinins; incubatedCPT4
- 86945Irradiation of blood product, each unitCPT4
- 86950Leukocyte transfusionCPT4
- 86960Volume reduction of blood or blood product (eg, red blood cells or platelets), each unitCPT4
- 86965Pooling of platelets or other blood productsCPT4
- 86970Pretreatment of RBCs for use in RBC antibody detection, identification, and/or compatibility testing; incubation with chemical agents or drugs, eachCPT4
- 86971Pretreatment of RBCs for use in RBC antibody detection, identification, and/or compatibility testing; incubation with enzymes, eachCPT4
- 86972Pretreatment of RBCs for use in RBC antibody detection, identification, and/or compatibility testing; by density gradient separationCPT4
- 86975Pretreatment of serum for use in RBC antibody identification; incubation with drugs, eachCPT4
- 86976Pretreatment of serum for use in RBC antibody identification; by dilutionCPT4
- 86977Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, eachCPT4
- 86978Pretreatment of serum for use in RBC antibody identification; by differential red cell absorption using patient RBCs or RBCs of known phenotype, each absorptionCPT4
- 86985Splitting of blood or blood products, each unitCPT4
- 86999Unlisted transfusion medicine procedureCPT4
- 87015Concentration (any type), for infectious agentsCPT4
- 87040Culture, bacterial; blood, aerobic, with isolation and presumptive identification of isolates (includes anaerobic culture, if appropriate)CPT4
- 87045Culture, bacterial; stool, aerobic, with isolation and preliminary examination (eg, KIA, LIA), Salmonella and Shigella speciesCPT4
- 87046Culture, bacterial; stool, aerobic, additional pathogens, isolation and presumptive identification of isolates, each plateCPT4
- 87060Culture, bacterial, definitive; throat or nose (Deprecated)CPT4
- 87070Culture, bacterial; any other source except urine, blood or stool, aerobic, with isolation and presumptive identification of isolatesCPT4
- 87071Culture, bacterial; quantitative, aerobic with isolation and presumptive identification of isolates, any source except urine, blood or stoolCPT4
- 87073Culture, bacterial; quantitative, anaerobic with isolation and presumptive identification of isolates, any source except urine, blood or stoolCPT4
- 87075Culture, bacterial; any source, except blood, anaerobic with isolation and presumptive identification of isolatesCPT4
- 87076Culture, bacterial; anaerobic isolate, additional methods required for definitive identification, each isolateCPT4
- 87077Culture, bacterial; aerobic isolate, additional methods required for definitive identification, each isolateCPT4
- 87081Culture, presumptive, pathogenic organisms, screening onlyCPT4
- 87084Culture, presumptive, pathogenic organisms, screening only; with colony estimation from density chartCPT4
- 87086Culture, bacterial; quantitative colony count, urineCPT4
- 87088Culture, bacterial; with isolation and presumptive identification of each isolate, urineCPT4
- 87101Culture, fungi (mold or yeast) isolation, with presumptive identification of isolates; skin, hair, or nailCPT4
- 87102Culture, fungi (mold or yeast) isolation, with presumptive identification of isolates; other source (except blood)CPT4
- 87103Culture, fungi (mold or yeast) isolation, with presumptive identification of isolates; bloodCPT4
- 87106Culture, fungi, definitive identification, each organism; yeastCPT4
- 87107Culture, fungi, definitive identification, each organism; moldCPT4
- 87109Culture, mycoplasma, any sourceCPT4
- 87110Culture, chlamydia, any sourceCPT4
- 87116Culture, tubercle or other acid-fast bacilli (eg, TB, AFB, mycobacteria) any source, with isolation and presumptive identification of isolatesCPT4
- 87118Culture, mycobacterial, definitive identification, each isolateCPT4
- 87140Culture, typing; immunofluorescent method, each antiserumCPT4
- 87143Culture, typing; gas liquid chromatography (GLC) or high pressure liquid chromatography (HPLC) methodCPT4
- 87147Culture, typing; immunologic method, other than immunofluorescence (eg, agglutination grouping), per antiserumCPT4
- 87149Culture, typing; identification by nucleic acid (DNA or RNA) probe, direct probe technique, per culture or isolate, each organism probedCPT4
- 87150Culture, typing; identification by nucleic acid (DNA or RNA) probe, amplified probe technique, per culture or isolate, each organism probedCPT4
- 87153Culture, typing; identification by nucleic acid sequencing method, each isolate (eg, sequencing of the 16S rRNA gene)CPT4
- 87158Culture, typing; other methodsCPT4
- 87164Dark field examination, any source (eg, penile, vaginal, oral, skin); includes specimen collectionCPT4
- 87168Macroscopic examination; arthropodCPT4
- 87169Macroscopic examination; parasiteCPT4
- 87172Pinworm exam (eg, cellophane tape prep)CPT4
- 87176Homogenization, tissue, for cultureCPT4
- 87177Ova and parasites, direct smears, concentration and identificationCPT4
- 87181Susceptibility studies, antimicrobial agent; agar dilution method, per agent (eg, antibiotic gradient strip)CPT4
- 87184Susceptibility studies, antimicrobial agent; disk method, per plate (12 or fewer agents)CPT4
- 87185Susceptibility studies, antimicrobial agent; enzyme detection (eg, beta lactamase), per enzymeCPT4
- 87186Susceptibility studies, antimicrobial agent; microdilution or agar dilution (minimum inhibitory concentration [MIC] or breakpoint), each multi-antimicrobial, per plateCPT4
- 87188Susceptibility studies, antimicrobial agent; macrobroth dilution method, each agentCPT4
- 87190Susceptibility studies, antimicrobial agent; mycobacteria, proportion method, each agentCPT4
- 87205Smear, primary source with interpretation; Gram or Giemsa stain for bacteria, fungi, or cell typesCPT4
- 87206Smear, primary source with interpretation; fluorescent and/or acid fast stain for bacteria, fungi, parasites, viruses or cell typesCPT4
- 87207Smear, primary source with interpretation; special stain for inclusion bodies or parasites (eg, malaria, coccidia, microsporidia, trypanosomes, herpes viruses)CPT4
- 87209Smear, primary source with interpretation; complex special stain (eg, trichrome, iron hemotoxylin) for ova and parasitesCPT4
- 87210Smear, primary source with interpretation; wet mount for infectious agents (eg, saline, India ink, KOH preps)CPT4
- 87220Tissue examination by KOH slide of samples from skin, hair, or nails for fungi or ectoparasite ova or mites (eg, scabies)CPT4
- 87230Toxin or antitoxin assay, tissue culture (eg, Clostridium difficile toxin)CPT4
- 87252Virus isolation; tissue culture inoculation, observation, and presumptive identification by cytopathic effectCPT4
- 87253Virus isolation; tissue culture, additional studies or definitive identification (eg, hemabsorption, neutralization, immunofluorescence stain), each isolateCPT4
- 87254Virus isolation; centrifuge enhanced (shell vial) technique, includes identification with immunofluorescence stain, each virusCPT4
- 87255Virus isolation; including identification by non-immunologic method, other than by cytopathic effect (eg, virus specific enzymatic activity)CPT4
- 87260Infectious agent antigen detection by immunofluorescent technique; adenovirusCPT4
- 87265Infectious agent antigen detection by immunofluorescent technique; Bordetella pertussis/parapertussisCPT4
- 87269Infectious agent antigen detection by immunofluorescent technique; giardiaCPT4
- 87270Infectious agent antigen detection by immunofluorescent technique; Chlamydia trachomatisCPT4
- 87271Infectious agent antigen detection by immunofluorescent technique; Cytomegalovirus, direct fluorescent antibody (DFA)CPT4
- 87272Infectious agent antigen detection by immunofluorescent technique; cryptosporidiumCPT4
- 87273Infectious agent antigen detection by immunofluorescent technique; Herpes simplex virus type 2CPT4
- 87274Infectious agent antigen detection by immunofluorescent technique; Herpes simplex virus type 1CPT4
- 87275Infectious agent antigen detection by immunofluorescent technique; influenza B virusCPT4
- 87276Infectious agent antigen detection by immunofluorescent technique; influenza A virusCPT4
- 87278Infectious agent antigen detection by immunofluorescent technique; Legionella pneumophilaCPT4
- 87279Infectious agent antigen detection by immunofluorescent technique; Parainfluenza virus, each typeCPT4
- 87280Infectious agent antigen detection by immunofluorescent technique; respiratory syncytial virusCPT4
- 87281Infectious agent antigen detection by immunofluorescent technique; Pneumocystis cariniiCPT4
- 87285Infectious agent antigen detection by immunofluorescent technique; Treponema pallidumCPT4
- 87290Infectious agent antigen detection by immunofluorescent technique; Varicella zoster virusCPT4
- 87299Infectious agent antigen detection by immunofluorescent technique; not otherwise specified, each organismCPT4
- 87300Infectious agent antigen detection by immunofluorescent technique, polyvalent for multiple organisms, each polyvalent antiserumCPT4
- 87301Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; adenovirus enteric types 40CPT4
- 87305Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; AspergillusCPT4
- 87320Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; Chlamydia trachomatisCPT4
- 87324Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; Clostridium difficile toxinCPT4
- 87327Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; Cryptococcus neoformansCPT4
- 87328Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; cryptosporidiumCPT4
- 87329Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; giardiaCPT4
- 87332Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; cytomegalovirusCPT4
- 87335Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; Escherichia coli 0157CPT4
- 87336Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; Entamoeba histolytica dispaCPT4
- 87337Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; Entamoeba histolytica groupCPT4
- 87338Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; Helicobacter pylori, stoolCPT4
- 87339Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; Helicobacter pyloriCPT4
- 87340Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; hepatitis B surface antigenCPT4
- 87341Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; hepatitis B surface antigenCPT4
- 87350Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; hepatitis Be antigen (HBeAgCPT4
- 87380Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; hepatitis, delta agentCPT4
- 87385Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; Histoplasma capsulatumCPT4
- 87389Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; HIV-1 antigen(s), with HIV-CPT4
- 87390Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; HIV-1CPT4
- 87400Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; Influenza, A or B, eachCPT4
- 87420Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; respiratory syncytial virusCPT4
- 87425Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; rotavirusCPT4
- 87426Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; severe acute respiratory syCPT4
- 87427Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; Shiga-like toxinCPT4
- 87428Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], fluorescence immunoassay [fia], immunochemiluminometric assay [imca]) qualitative or semiquantitative; severe acute r...CPT4
- 87430Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; Streptococcus, group ACPT4
- 87449Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; multiple-step method, not otherwise specified, eCPT4
- 87450Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; single-step method, not otherwise specified, eacCPT4
- 87471Infectious agent detection by nucleic acid (DNA or RNA); Bartonella henselae and Bartonella quintana, amplified probe techniqueCPT4
- 87475Infectious agent detection by nucleic acid (DNA or RNA); Borrelia burgdorferi, direct probe techniqueCPT4
- 87476Infectious agent detection by nucleic acid (DNA or RNA); Borrelia burgdorferi, amplified probe techniqueCPT4
- 87480Infectious agent detection by nucleic acid (DNA or RNA); Candida species, direct probe techniqueCPT4
- 87481Infectious agent detection by nucleic acid (DNA or RNA); Candida species, amplified probe techniqueCPT4
- 87482Infectious agent detection by nucleic acid (DNA or RNA); Candida species, quantificationCPT4
- 87483Infectious agent detection by nucleic acid (DNA or RNA); central nervous system pathogen (eg, Neisseria meningitidis, Streptococcus pneumoniae, Listeria, Haemophilus influenzae, E. coli, Streptococcus agalactiae, enterovirus, human parechovirus, herpes siCPT4
- 87486Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia pneumoniae, amplified probe techniqueCPT4
- 87490Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, direct probe techniqueCPT4
- 87491Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe techniqueCPT4
- 87492Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, quantificationCPT4
- 87493Infectious agent detection by nucleic acid (DNA or RNA); Clostridium difficile, toxin gene(s), amplified probe techniqueCPT4
- 87496Infectious agent detection by nucleic acid (DNA or RNA); cytomegalovirus, amplified probe techniqueCPT4
- 87497Infectious agent detection by nucleic acid (DNA or RNA); cytomegalovirus, quantificationCPT4
- 87498Infectious agent detection by nucleic acid (DNA or RNA); enterovirus, amplified probe technique, includes reverse transcription when performedCPT4
- 87500Infectious agent detection by nucleic acid (DNA or RNA); vancomycin resistance (eg, enterococcus species van A, van B), amplified probe techniqueCPT4
- 87501Infectious agent detection by nucleic acid (DNA or RNA); influenza virus, includes reverse transcription, when performed, and amplified probe technique, each type or subtypeCPT4
- 87502Infectious agent detection by nucleic acid (DNA or RNA); influenza virus, for multiple types or sub-types, includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, first 2 types or sub-typesCPT4
- 87503Infectious agent detection by nucleic acid (DNA or RNA); influenza virus, for multiple types or sub-types, includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, each additional influenza virus type or sub-type CPT4
- 87505Infectious agent detection by nucleic acid (DNA or RNA); gastrointestinal pathogen (eg, Clostridium difficile, E. coli, Salmonella, Shigella, norovirus, Giardia), includes multiplex reverse transcription, when performed, and multiplex amplified probe techCPT4
- 87506Infectious agent detection by nucleic acid (DNA or RNA); gastrointestinal pathogen (eg, Clostridium difficile, E. coli, Salmonella, Shigella, norovirus, Giardia), includes multiplex reverse transcription, when performed, and multiplex amplified probe techCPT4
- 87507Infectious agent detection by nucleic acid (DNA or RNA); gastrointestinal pathogen (eg, Clostridium difficile, E. coli, Salmonella, Shigella, norovirus, Giardia), includes multiplex reverse transcription, when performed, and multiplex amplified probe techCPT4
- 87510Infectious agent detection by nucleic acid (DNA or RNA); Gardnerella vaginalis, direct probe techniqueCPT4
- 87511Infectious agent detection by nucleic acid (DNA or RNA); Gardnerella vaginalis, amplified probe techniqueCPT4
- 87512Infectious agent detection by nucleic acid (DNA or RNA); Gardnerella vaginalis, quantificationCPT4
- 87516Infectious agent detection by nucleic acid (DNA or RNA); hepatitis B virus, amplified probe techniqueCPT4
- 87517Infectious agent detection by nucleic acid (DNA or RNA); hepatitis B virus, quantificationCPT4
- 87520Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, direct probe techniqueCPT4
- 87521Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, amplified probe technique, includes reverse transcription when performedCPT4
- 87522Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, quantification, includes reverse transcription when performedCPT4
- 87529Infectious agent detection by nucleic acid (DNA or RNA); Herpes simplex virus, amplified probe techniqueCPT4
- 87530Infectious agent detection by nucleic acid (DNA or RNA); Herpes simplex virus, quantificationCPT4
- 87532Infectious agent detection by nucleic acid (DNA or RNA); Herpes virus-6, amplified probe techniqueCPT4
- 87533Infectious agent detection by nucleic acid (DNA or RNA); Herpes virus-6, quantificationCPT4
- 87535Infectious agent detection by nucleic acid (DNA or RNA); HIV-1, amplified probe technique, includes reverse transcription when performedCPT4
- 87536Infectious agent detection by nucleic acid (DNA or RNA); HIV-1, quantification, includes reverse transcription when performedCPT4
- 87538Infectious agent detection by nucleic acid (DNA or RNA); HIV-2, amplified probe technique, includes reverse transcription when performedCPT4
- 87539Infectious agent detection by nucleic acid (DNA or RNA); HIV-2, quantification, includes reverse transcription when performedCPT4
- 87540Infectious agent detection by nucleic acid (DNA or RNA); Legionella pneumophila, direct probe techniqueCPT4
- 87541Infectious agent detection by nucleic acid (DNA or RNA); Legionella pneumophila, amplified probe techniqueCPT4
- 87542Infectious agent detection by nucleic acid (DNA or RNA); Legionella pneumophila, quantificationCPT4
- 87551Infectious agent detection by nucleic acid (DNA or RNA); Mycobacteria species, amplified probe techniqueCPT4
- 87552Infectious agent detection by nucleic acid (DNA or RNA); Mycobacteria species, quantificationCPT4
- 87556Infectious agent detection by nucleic acid (DNA or RNA); Mycobacteria tuberculosis, amplified probe techniqueCPT4
- 87561Infectious agent detection by nucleic acid (DNA or RNA); Mycobacteria avium-intracellulare, amplified probe techniqueCPT4
- 87563Infectious agent detection by nucleic acid (DNA or RNA); Mycoplasma genitalium, amplified probe techniqueCPT4
- 87581Infectious agent detection by nucleic acid (DNA or RNA); Mycoplasma pneumoniae, amplified probe techniqueCPT4
- 87582Infectious agent detection by nucleic acid (DNA or RNA); Mycoplasma pneumoniae, quantificationCPT4
- 87590Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, direct probe techniqueCPT4
- 87591Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe techniqueCPT4
- 87592Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, quantificationCPT4
- 87623Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), low-risk types (eg, 6, 11, 42, 43, 44)CPT4
- 87624Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), high-risk types (eg, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68)CPT4
- 87625Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), types 16 and 18 only, includes type 45, if performedCPT4
- 87631Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when perforCPT4
- 87632Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when perforCPT4
- 87633Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when perforCPT4
- 87634Infectious agent detection by nucleic acid (DNA or RNA); respiratory syncytial virus, amplified probe techniqueCPT4
- 87635Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe techniqueCPT4
- 87636Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) and influenza virus types a and b, multiplex amplified probe techniqueCPT4
- 87637Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), influenza virus types a and b, and respiratory syncytial virus, multiplex amplified probe techniqueCPT4
- 87640Infectious agent detection by nucleic acid (DNA or RNA); Staphylococcus aureus, amplified probe techniqueCPT4
- 87641Infectious agent detection by nucleic acid (DNA or RNA); Staphylococcus aureus, methicillin resistant, amplified probe techniqueCPT4
- 87650Infectious agent detection by nucleic acid (DNA or RNA); Streptococcus, group A, direct probe techniqueCPT4
- 87651Infectious agent detection by nucleic acid (DNA or RNA); Streptococcus, group A, amplified probe techniqueCPT4
- 87652Infectious agent detection by nucleic acid (DNA or RNA); Streptococcus, group A, quantificationCPT4
- 87653Infectious agent detection by nucleic acid (DNA or RNA); Streptococcus, group B, amplified probe techniqueCPT4
- 87660Infectious agent detection by nucleic acid (DNA or RNA); Trichomonas vaginalis, direct probe techniqueCPT4
- 87661Infectious agent detection by nucleic acid (DNA or RNA); Trichomonas vaginalis, amplified probe techniqueCPT4
- 87662Infectious agent detection by nucleic acid (DNA or RNA); Zika virus, amplified probe techniqueCPT4
- 87797Infectious agent detection by nucleic acid (DNA or RNA), not otherwise specified; direct probe technique, each organismCPT4
- 87798Infectious agent detection by nucleic acid (DNA or RNA), not otherwise specified; amplified probe technique, each organismCPT4
- 87799Infectious agent detection by nucleic acid (DNA or RNA), not otherwise specified; quantification, each organismCPT4
- 87800Infectious agent detection by nucleic acid (DNA or RNA), multiple organisms; direct probe(s) techniqueCPT4
- 87801Infectious agent detection by nucleic acid (DNA or RNA), multiple organisms; amplified probe(s) techniqueCPT4
- 87802Infectious agent antigen detection by immunoassay with direct optical observation; Streptococcus, group BCPT4
- 87803Infectious agent antigen detection by immunoassay with direct optical observation; Clostridium difficile toxin ACPT4
- 87804Infectious agent antigen detection by immunoassay with direct optical observation; InfluenzaCPT4
- 87806Infectious agent antigen detection by immunoassay with direct optical observation; HIV-1 antigen(s), with HIV-1 and HIV-2 antibodiesCPT4
- 87807Infectious agent antigen detection by immunoassay with direct optical observation; respiratory syncytial virusCPT4
- 87808Infectious agent antigen detection by immunoassay with direct optical observation; Trichomonas vaginalisCPT4
- 87809Infectious agent antigen detection by immunoassay with direct optical observation; adenovirusCPT4
- 87810Infectious agent antigen detection by immunoassay with direct optical observation; Chlamydia trachomatisCPT4
- 87811Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19])CPT4
- 87880Infectious agent antigen detection by immunoassay with direct optical observation; Streptococcus, group ACPT4
- 87899Infectious agent antigen detection by immunoassay with direct optical observation; not otherwise specifiedCPT4
- 87900Infectious agent drug susceptibility phenotype prediction using regularly updated genotypic bioinformaticsCPT4
- 87901Infectious agent genotype analysis by nucleic acid (DNA or RNA); HIV-1, reverse transcriptase and protease regionsCPT4
- 87902Infectious agent genotype analysis by nucleic acid (DNA or RNA); Hepatitis C virusCPT4
- 87903Infectious agent phenotype analysis by nucleic acid (DNA or RNA) with drug resistance tissue culture analysis, HIV 1; first through 10 drugs testedCPT4
- 87904Infectious agent phenotype analysis by nucleic acid (DNA or RNA) with drug resistance tissue culture analysis, HIV 1; each additional drug tested (List separately in addition to code for primary procedure)CPT4
- 87905Infectious agent enzymatic activity other than virus (eg, sialidase activity in vaginal fluid)CPT4
- 87906Infectious agent genotype analysis by nucleic acid (DNA or RNA); HIV-1, other region (eg, integrase, fusion)CPT4
- 87910Infectious agent genotype analysis by nucleic acid (DNA or RNA); cytomegalovirusCPT4
- 87912Infectious agent genotype analysis by nucleic acid (DNA or RNA); Hepatitis B virusCPT4
- 87999Unlisted microbiology procedureCPT4
- 88012Necropsy (autopsy), gross examination only; infant with brainCPT4
- 88016Necropsy (autopsy), gross examination only; macerated stillbornCPT4
- 88036Necropsy (autopsy), limited, gross and/or microscopic; regionalCPT4
- 88104Cytopathology, fluids, washings or brushings, except cervical or vaginal; smears with interpretationCPT4
- 88106Cytopathology, fluids, washings or brushings, except cervical or vaginal; simple filter method with interpretationCPT4
- 88108Cytopathology, concentration technique, smears and interpretation (eg, Saccomanno technique)CPT4
- 88112Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginalCPT4
- 88120Cytopathology, in situ hybridization (eg, FISH), urinary tract specimen with morphometric analysis, 3-5 molecular probes, each specimen; manualCPT4
- 88121Cytopathology, in situ hybridization (eg, FISH), urinary tract specimen with morphometric analysis, 3-5 molecular probes, each specimen; using computer-assisted technologyCPT4
- 88125Cytopathology, forensic (eg, sperm)CPT4
- 88141Cytopathology, cervical or vaginal (any reporting system), requiring interpretation by physicianCPT4
- 88142Cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation; manual screening under physician supervisionCPT4
- 88143Cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation; with manual screening and rescreening under physician supervisionCPT4
- 88145Cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation; with manual screening and computer-assisted rescreening using cell selection and review under physician supervision (Deprecated)CPT4
- 88147Cytopathology smears, cervical or vaginal; screening by automated system under physician supervisionCPT4
- 88150Cytopathology, slides, cervical or vaginal; manual screening under physician supervisionCPT4
- 88160Cytopathology, smears, any other source; screening and interpretationCPT4
- 88161Cytopathology, smears, any other source; preparation, screening and interpretationCPT4
- 88162Cytopathology, smears, any other source; extended study involving over 5 slides and/or multiple stainsCPT4
- 88164Cytopathology, slides, cervical or vaginal (the Bethesda System); manual screening under physician supervisionCPT4
- 88172Cytopathology, evaluation of fine needle aspirate; immediate cytohistologic study to determine adequacy for diagnosis, first evaluation episode, each siteCPT4
- 88173Cytopathology, evaluation of fine needle aspirate; interpretation and reportCPT4
- 88174Cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation; screening by automated system, under physician supervisionCPT4
- 88175Cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation; with screening by automated system and manual rescreening or review, under physician supervisionCPT4
- 88177Cytopathology, evaluation of fine needle aspirate; immediate cytohistologic study to determine adequacy for diagnosis, each separate additional evaluation episode, same site (List separately in addition to code for primary procedure)CPT4
- 88182Flow cytometry, cell cycle or DNA analysisCPT4
- 88184Flow cytometry, cell surface, cytoplasmic, or nuclear marker, technical component only; first markerCPT4
- 88185Flow cytometry, cell surface, cytoplasmic, or nuclear marker, technical component only; each additional marker (List separately in addition to code for first marker)CPT4
- 88187Flow cytometry, interpretation; 2 to 8 markersCPT4
- 88188Flow cytometry, interpretation; 9 to 15 markersCPT4
- 88189Flow cytometry, interpretation; 16 or more markersCPT4
- 88199Unlisted cytopathology procedureCPT4
- 88230Tissue culture for non-neoplastic disorders; lymphocyteCPT4
- 88233Tissue culture for non-neoplastic disorders; skin or other solid tissue biopsyCPT4
- 88235Tissue culture for non-neoplastic disorders; amniotic fluid or chorionic villus cellsCPT4
- 88237Tissue culture for neoplastic disorders; bone marrow, blood cellsCPT4
- 88239Tissue culture for neoplastic disorders; solid tumorCPT4
- 88240Cryopreservation, freezing and storage of cells, each cell lineCPT4
- 88241Thawing and expansion of frozen cells, each aliquotCPT4
- 88248Chromosome analysis for breakage syndromes; baseline breakage, score 50-100 cells, count 20 cells, 2 karyotypes (eg, for ataxia telangiectasia, Fanconi anemia, fragile X)CPT4
- 88249Chromosome analysis for breakage syndromes; score 100 cells, clastogen stress (eg, diepoxybutane, mitomycin C, ionizing radiation, UV radiation)CPT4
- 88261Chromosome analysis; count 5 cells, 1 karyotype, with bandingCPT4
- 88262Chromosome analysis; count 15-20 cells, 2 karyotypes, with bandingCPT4
- 88263Chromosome analysis; count 45 cells for mosaicism, 2 karyotypes, with bandingCPT4
- 88264Chromosome analysis; analyze 20-25 cellsCPT4
- 88267Chromosome analysis, amniotic fluid or chorionic villus, count 15 cells, 1 karyotype, with bandingCPT4
- 88269Chromosome analysis, in situ for amniotic fluid cells, count cells from 6-12 colonies, 1 karyotype, with bandingCPT4
- 88271Molecular cytogenetics; DNA probe, each (eg, FISH)CPT4
- 88272Molecular cytogenetics; chromosomal in situ hybridization, analyze 3-5 cells (eg, for derivatives and markers)CPT4
- 88273Molecular cytogenetics; chromosomal in situ hybridization, analyze 10-30 cells (eg, for microdeletions)CPT4
- 88274Molecular cytogenetics; interphase in situ hybridization, analyze 25-99 cellsCPT4
- 88275Molecular cytogenetics; interphase in situ hybridization, analyze 100-300 cellsCPT4
- 88280Chromosome analysis; additional karyotypes, each studyCPT4
- 88283Chromosome analysis; additional specialized banding technique (eg, NOR, C-banding)CPT4
- 88285Chromosome analysis; additional cells counted, each studyCPT4
- 88289Chromosome analysis; additional high resolution studyCPT4
- 88291Cytogenetics and molecular cytogenetics, interpretation and reportCPT4
- 88300Level I - Surgical pathology, gross examination onlyCPT4
- 88302Level II - Surgical pathology, gross and microscopic examination Appendix, incidental Fallopian tube, sterilization Fingers/toes, amputation, traumatic Foreskin, newborn Hernia sac, any location Hydrocele sac Nerve Skin, plastic repair Sympathetic ganglioCPT4
- 88304Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologiCPT4
- 88305Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgicaCPT4
- 88307Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation ofCPT4
- 88309Level VI - Surgical pathology, gross and microscopic examination Bone resection Breast, mastectomy - with regional lymph nodes Colon, segmental resection for tumor Colon, total resection Esophagus, partial/total resection Extremity, disarticulation Fetus,CPT4
- 88311Decalcification procedure (List separately in addition to code for surgical pathology examination)CPT4
- 88312Special stain including interpretation and report; Group I for microorganisms (eg, acid fast, methenamine silver)CPT4
- 88313Special stain including interpretation and report; Group II, all other (eg, iron, trichrome), except stain for microorganisms, stains for enzyme constituents, or immunocytochemistry and immunohistochemistryCPT4
- 88314Special stain including interpretation and report; histochemical stain on frozen tissue block (List separately in addition to code for primary procedure)CPT4
- 88319Special stain including interpretation and report; Group III, for enzyme constituentsCPT4
- 88321Consultation and report on referred slides prepared elsewhereCPT4
- 88323Consultation and report on referred material requiring preparation of slidesCPT4
- 88325Consultation, comprehensive, with review of records and specimens, with report on referred materialCPT4
- 88329Pathology consultation during surgeryCPT4
- 88331Pathology consultation during surgery; first tissue block, with frozen section(s), single specimenCPT4
- 88332Pathology consultation during surgery; each additional tissue block with frozen section(s) (List separately in addition to code for primary procedure)CPT4
- 88333Pathology consultation during surgery; cytologic examination (eg, touch prep, squash prep), initial siteCPT4
- 88334Pathology consultation during surgery; cytologic examination (eg, touch prep, squash prep), each additional site (List separately in addition to code for primary procedure)CPT4
- 88341Immunohistochemistry or immunocytochemistry, per specimen; each additional single antibody stain procedure (List separately in addition to code for primary procedure)CPT4
- 88342Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedureCPT4
- 88344Immunohistochemistry or immunocytochemistry, per specimen; each multiplex antibody stain procedureCPT4
- 88346Immunofluorescence, per specimen; initial single antibody stain procedureCPT4
- 88348Electron microscopy, diagnosticCPT4
- 88350Immunofluorescence, per specimen; each additional single antibody stain procedure (List separately in addition to code for primary procedure)CPT4
- 88355Morphometric analysis; skeletal muscleCPT4
- 88356Morphometric analysis; nerveCPT4
- 88358Morphometric analysis; tumor (eg, DNA ploidy)CPT4
- 88360Morphometric analysis, tumor immunohistochemistry (eg, Her-2/neu, estrogen receptor/progesterone receptor), quantitative or semiquantitative, per specimen, each single antibody stain procedure; manualCPT4
- 88361Morphometric analysis, tumor immunohistochemistry (eg, Her-2/neu, estrogen receptor/progesterone receptor), quantitative or semiquantitative, per specimen, each single antibody stain procedure; using computer-assisted technologyCPT4
- 88362Nerve teasing preparationsCPT4
- 88363Examination and selection of retrieved archival (ie, previously diagnosed) tissue(s) for molecular analysis (eg, KRAS mutational analysis)CPT4
- 88364In situ hybridization (eg, FISH), per specimen; each additional single probe stain procedure (List separately in addition to code for primary procedure)CPT4
- 88365In situ hybridization (eg, FISH), per specimen; initial single probe stain procedureCPT4
- 88366In situ hybridization (eg, FISH), per specimen; each multiplex probe stain procedureCPT4
- 88367Morphometric analysis, in situ hybridization (quantitative or semi-quantitative), using computer-assisted technology, per specimen; initial single probe stain procedureCPT4
- 88368Morphometric analysis, in situ hybridization (quantitative or semi-quantitative), manual, per specimen; initial single probe stain procedureCPT4
- 88369Morphometric analysis, in situ hybridization (quantitative or semi-quantitative), manual, per specimen; each additional single probe stain procedure (List separately in addition to code for primary procedure)CPT4
- 88371Protein analysis of tissue by Western Blot, with interpretation and reportCPT4
- 88373Morphometric analysis, in situ hybridization (quantitative or semi-quantitative), using computer-assisted technology, per specimen; each additional single probe stain procedure (List separately in addition to code for primary procedure)CPT4
- 88374Morphometric analysis, in situ hybridization (quantitative or semi-quantitative), using computer-assisted technology, per specimen; each multiplex probe stain procedureCPT4
- 88377Morphometric analysis, in situ hybridization (quantitative or semi-quantitative), manual, per specimen; each multiplex probe stain procedureCPT4
- 88380Microdissection (ie, sample preparation of microscopically identified target); laser captureCPT4
- 88381Microdissection (ie, sample preparation of microscopically identified target); manualCPT4
- 88387Macroscopic examination, dissection, and preparation of tissue for non-microscopic analytical studies (eg, nucleic acid-based molecular studies); each tissue preparation (eg, a single lymph node)CPT4
- 88399Unlisted surgical pathology procedureCPT4
- 88720Bilirubin, total, transcutaneousCPT4
- 88738Hemoglobin (Hgb), quantitative, transcutaneousCPT4
- 88740Hemoglobin, quantitative, transcutaneous, per day; carboxyhemoglobinCPT4
- 89050Cell count, miscellaneous body fluids (eg, cerebrospinal fluid, joint fluid), except bloodCPT4
- 89051Cell count, miscellaneous body fluids (eg, cerebrospinal fluid, joint fluid), except blood; with differential countCPT4
- 89055Leukocyte assessment, fecal, qualitative or semiquantitativeCPT4
- 89060Crystal identification by light microscopy with or without polarizing lens analysis, tissue or any body fluid (except urine)CPT4
- 89125Fat stain, feces, urine, or respiratory secretionsCPT4
- 89160Meat fibers, fecesCPT4
- 89190Nasal smear for eosinophilsCPT4
- 89220Sputum, obtaining specimen, aerosol induced technique (separate procedure)CPT4
- 89230Sweat collection by iontophoresisCPT4
- 89240Unlisted miscellaneous pathology testCPT4
- 89254Oocyte identification from follicular fluidCPT4
- 89255Preparation of embryo for transfer (any method)CPT4
- 89258Cryopreservation; embryo(s)CPT4
- 89259Cryopreservation; spermCPT4
- 89260Sperm isolation; simple prep (eg, sperm wash and swim-up) for insemination or diagnosis with semen analysisCPT4
- 89261Sperm isolation; complex prep (eg, Percoll gradient, albumin gradient) for insemination or diagnosis with semen analysisCPT4
- 89264Sperm identification from testis tissue, fresh or cryopreservedCPT4
- 89272Extended culture of oocyte(s)/embryo(s), 4-7 daysCPT4
- 89281Assisted oocyte fertilization, microtechnique; greater than 10 oocytesCPT4
- 89300Semen analysis; presence and/or motility of sperm including Huhner test (post coital)CPT4
- 89310Semen analysis; motility and count (not including Huhner test)CPT4
- 89320Semen analysis; volume, count, motility, and differentialCPT4
- 89321Semen analysis; sperm presence and motility of sperm, if performedCPT4
- 89322Semen analysis; volume, count, motility, and differential using strict morphologic criteria (eg, Kruger)CPT4
- 89325Sperm antibodiesCPT4
- 89342Storage (per year); embryo(s)CPT4
- 89343Storage (per year); sperm/semenCPT4
- 89352Thawing of cryopreserved; embryo(s)CPT4
- 89353Thawing of cryopreserved; sperm/semen, each aliquotCPT4